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Verotoxinogenic  Escherichia coli O157:H7 in Swedish Cattle 
and Pigs  
Abstract 
Verotoxinogenic E. coli O157:H7 (VTEC O157:H7) can cause severe disease in 
humans, with bloody diarrhea and complications such as haemolytic uraemic 
syndrome (HUS), thrombotic thrombocytopenic purpura (TTP) and even death. 
Animals carry VTEC O157:H7 asymptomatically. Ruminants, especially cattle, are 
considered to be the main reservoir, although the bacterium can occasionally be 
isolated from other species, such as pigs.   
The main aim of this thesis was to increase our knowledge of VTEC O157:H7 in 
Swedish cattle and pigs and to assess the extent to which they could be a potential 
source of human infections. The studies have included prevalence investigations of 
VTEC O157:H7 in slaughtered Swedish cattle and pigs, with estimated prevalences 
of 1.2% and 0.1%, respectively. Moreover, a study was performed on 371 dairy 
herds, where VTEC O157:H7 was detected in 8.9% of the herds. Indentified risk 
factors for herds to prove positive were: median age of sampled animals, herd size, 
farms located in Halland and presence of pigs on a dairy farm. Studies were also 
performed on farms where pigs shed VTEC O157:H7. Direct or indirect contact 
with ruminants seemed to be of major importance for presence of the bacterium in 
pigs. Young pigs were monitored during rearing for slaughter and were found to rid 
themselves of the bacteria prior to slaughter. When VTEC O157:H7 isolates from 
the cattle prevalence studies (n=181) and farms linked to human cases (n=19) were 
subtyped, a specific variant, VTEC O157:H7 (PT4:vtx2,vtx2c), predominated among 
the strains isolated from farms associated with disease in humans. By extended 
subtyping it was established that strains of this specific variant belonged to a group 
of putative hyper-virulent strains, clade 8, suspected of causing more severe disease 
in humans. Furthermore, different molecular subtyping techniques were evaluated 
regarding their ability to distinguish between VTEC O157:H7 strains isolated from 
Swedish cattle and pigs.  
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1  Introduction  
1.1  Escherichia coli 
Escherichia coli was first described in 1885 by Theodor Escherich (Escherich, 
1988). Escherich, a Bavarian paediatrician, had performed studies on the 
intestinal flora of infants and had discovered a normal microbial inhabitant in 
healthy individuals, which he named Bacterium coli commune. In 1919, the 
bacterium was renamed in his honour to Escherichia coli (Kaper, 2005) 
The species E. coli comprises gram-negative, oxidase-negative straight 
cylindrical rods measuring 1.1-1.5 x 2.0-6.0 µm. They are aerobic and 
facultative anaerobic, rendered motile by peritrichous flagella, or non-motile 
(Scheutz  & Strockbine, 2005).  
 
The taxonomy of E. coli is summarized below 
 
Phylum  Proteobacteria 
Class     Gammaproteobacteria 
Order  Enterobacteriales 
Family   Enterobacteriaceae 
Genus  Escherichia 
Species   Escherichia coli           (VetBakt,  2007) 
 
The 16S rRNA based phylogenetic tree shown in Fig. 1 illustrates its 
relatedness with other representatives of genera within the Enterobacteriaceae 
family. Phylogenetic analysis has demonstrated a very close relation between 
E. coli, Salmonella spp. and Citrobacter freundii. With the exception of Shigella 
boydii serotype 13, the four species of Shigella, (S. dysentieriae S. flexneri, S. 
boydi and S. sonnei) show such a high degree of relatedness to E. coli that 
these five could be considered a single species. However, the distinction still 
prevails, for historical and medical reasons (reviewed by Scheutz  & 
Strockbine, 2005).   12
 
Figure 1. Evolutionary tree showing the phylogenetic relations of the Enterobacteriaceae family. 
Superscript T indicates type strains.  
E. coli can be characterized by serotyping, a method based on differences in 
antigenic structure on the bacterial surface. The serotype is defined by the 
bacterium’s O-antigen (Ohne), a polysaccharide domain in the bacterium’s 
lipopolysaccharide (LPS) in the outer membrane, and the H-antigen 
(Hauch) consisting of flagella protein. Serotyping may also include the K-
antigen (Kapsel) and the F-antigen (Fimbriae). There are many known O, 
H, K and F antigens and the existing number of different serotypes is known 
to be very high. Serotyping is an important tool which can be used in 
combination with other methods to distinguish pathogenic E. coli strains as 
specific pathogenicity attributes are often linked to certain serotypes. (Gyles, 
2007; Kaper, 2005; Scheutz  & Strockbine, 2005)  
1.2  Pathogenic E. coli 
Most Escherichia coli are harmless commensals which are part of the natural 
gastrointestinal flora in the lower intestine of warm-blooded animals. They 
are considered beneficial for maintaining a healthy intestinal ecosystem and 
have even been candidates for probiotic treatment to counteract a variety of 
enteric diseases. However, some subsets of E. coli have acquired specific 
virulence attributes that render them capable of causing a variety of illnesses 
in healthy humans and animals (Kaper et al., 2004).  
Interestingly, most acquired virulence factors that distinguish pathogenic 
E. coli from commensals are encoded by mobile genetic elements such as 
plasmids, bacteriophages and transposons. Genes coding for virulence factors 
are often located in the chromosome on pathogenicity islands (PAI), large 
genomic regions that cannot be found in commensals. These often include 
genetic elements that might once have been mobile but subsequently 
evolved to be locked into the genome (PEN, 2006b; Scheutz  & 
Strockbine, 2005; Kaper et al., 2004).The pathogenic E. coli are divided into 
different pathotypes according to the virulence factors they possess. In 
Tables 1 and 2 different pathotypes of E. coli in humans are described.   13 
Table 1. Intestinal pathogenic E. coli 
Pathotype, Mode of action  Main virulence factors 
EPEC Enteropathogenic E. coli 
  Adheres to small intestine enterocytes, 
destroys normal microvillar architecture, 
produces attaching and effacing lesions, an 
inflammatory response, increased intestinal 
permeability, active ion secretion.  
Watery to bloody diarrhea 
 
Pathogenicity island LEE,  
-Type III secretion system, intimin, Tir,  
EspA, EspB, EspD, EspF  
EPEC adherence factor (EAF) plasmid  
 - Bundle-forming pili (BPF)  
 - Plasmid-encoded regulator (Per) 
No classic toxins produced 
(atypical EPEC lacks EAF plasmid) 
 
ETEC  Enterotoxigenic E. coli 
  Adheres to small intestine enterocytes, 
Secretion of enterotoxins, cAMP, cGMP, 
stimulation of chloride secretion and 
inhibition of sodium absorption.  
Watery diarrhea 
Colonization factor antigens (CFA) 
Heat-labile toxin (LT) 
Heat-stabile toxin (STa, STb) 
  
EHEC Enterohaemorrhagic E. coli 
  Adheres to large intestine enterocytes, 
destroys normal microvillar architecture, 
produces attaching and effacing lesions,  
causes apoptosis, cell death and inflammarory 
respons. Watery to bloody diarrhea.  
Systemic absorption of VT may lead to 
HUS, acute renal failure, TTP, neurological 
disorders. 
Pathogenicity island LEE  
Type III secretion system, intimin, Tir,  
EspA, EspB, EspD, EspF  
Verotoxins VT1, VT2 
pO157 Plasmid 
- Enterohaemolysin  (EHEC-Hly) 
- Serine protease (EspP)  
- ToxB 
  
EIEC Enteroinvasive E. coli 
  Invades the colonic epithelial cell, lyses 
phagosomes, multiplies, moves through the 
cell, migrates into adjacent cells,  
causes inflammatory invasive colitis. 
Watery to bloody diarrhea 
 
Invasion plasmid (pINV) 
- IpA, IpB,  IpC, IpD 
- IscA 
EAEC/ EAggEC 
Enteroaggregative E. coli 
Adheres to the small and large intestinal 
epithelia in a thick biofilm, causes increased 
mucus production, produces secretory 
enterotoxins and cytotoxins. 
Watery mucoid diarrhea, may be persistent 
 
Aggregative adherence fimbrieae (AAFs) 
EAEC flagellin 
Toxins (Pic, ShET1, EAST, Pet) 
DAEC  Diffusely adherent E. coli  
  Adheres and induces a cytopathic effect 
that makes small intestine enterocytes grow 
long, finger-like projections which wrap 
around the bacteria. Diarrhea 
Dr adhesion family  
Fimbrial adhesin F1845 
   14
Table 2. Extra-intestinal pathogenic E. coli (ExPEC) 
Pathotype, Mode of action  Main virulence factors 
UPEC  Uropathogenic E. coli 
  Colonizes periurethral area, ascends the 
urethra to urine bladder, attaches and invades 
epithelial cells, may ascend to kidney.  
Cystitis and pyelonephritis 
Adhesins (typ 1, F1C, S, M, Dr) 
P fimbriae (Pap)  
Cytotoxic necrotizing factor (CNF-1) 
Haemolysin (HlyA) 
Autotransported protease (Sat) 
  
MNEC   
Meningitis/sepsis-associated E. coli  
  Spreads haematogeneously, translocates 
from blod to CNS without damaging blood-
brain barrier. 
Neonatal meningitis 
Outer membrane proteins (OmpA, IbA, 
IbeB, IbeC, AsIA) 
Cytotoxic necrotizing factor (CNF-1) 
K1 kapsule 
1.3  EHEC/VTEC/STEC  
1.3.1  Enterohaemorrhagic E. coli (EHEC)  
Enterohaemorrhagic E. coli (EHEC) consists of a subset of E. coli strains that 
are known to be pathogenic to humans, i.e. they have the same clinical and 
pathogenic features associated with the EHEC prototype organism, E. coli 
O157:H7 (Levine et al., 1987). In practice the definition EHEC is used to 
describe the subgroup of verotoxin producing E. coli that have the potential 
to cause haemorrhagic colitis (HC) in humans (reviewed by Scheutz  & 
Strockbine, 2005). 
1.3.2  Nomenclature VTEC/STEC 
The cardinal virulence factor for EHEC is their ability to produce 
verotoxins (VT). These toxins are synonymously called shiga toxins (Stx), 
because of their similarity to those produced by Shigella dysenteriae. 
Consequently the E. coli bacteria that produce VT are called verotoxin-
producing E. coli (VTEC) or Shiga toxin-producing E. coli (STEC). These 
designations, VT/Stx and VTEC/STEC, are used interchangeably.  
1.3.3  Seropathotypes 
VTEC is considered a natural habitant in ruminants and VTEC is very 
frequently isolated from these animals. However, only a small subset of 
VTEC from ruminants should be considered as potential human pathogens, 
as VT alone is not sufficient to induce human disease (Law, 2000; Blanco et 
al., 1996).   15 
More than 400 different serotypes of VTEC have been isolated from 
humans but only few are associated with the majority of human EHEC cases 
(Scheutz  & Strockbine, 2005). A classification system based on the concept 
of “seropathotypes” has been compiled by Karmali and colleagues. (Karmali 
et al., 2003). This system classifies VTEC serotypes according to their ability 
to induce disease. The serotypes are ranked in five groups (A-E) ranging 
from the most pathogenic serotypes (A) to those that have never been 
associated with human disease (E). This classification is based on the 
reported occurrence of different serotypes in human outbreaks and by the 
frequency with which they are reported to have induced haemolytic 
uraemic syndrome (HUS) (See Table 3). 
Table 3. The classification of VTEC serotypes into seropathotypes (adapted from Karmali et al. 2003)  
 
Sero- 
pathotype  
 
Relative 
incidence 
Frequency of 
involvement in 
outbreaks 
Association 
with severe 
disease
a 
 
Serotypes 
A High  Common  Yes  O157:H7,  O157:H- 
 
B Moderate  Uncommon  Yes  O26:H11,  O103:H2, 
O111:NM, O121:H19, 
O145:NM 
 
C Low  Rare  Yes  O91:H21,  O104:H21, 
O113:H21; others 
 
D Low  Rare  No  Multiple 
 
E Non-human  only  NA
b NA
b Multiple 
a 
HUS or hemorrhagic colitis  
b NA, not applicable 
The panel of the European Food Safety Authority (EFSA) concerned with 
Biological Hazards has recommended that animal and foodstuffs monitoring 
in the EU should initially be concentrated on VTEC O157, since this 
serotype is most frequently associated with severe human infections and 
HUS, but that monitoring should be extended to other serotypes such as 
O26, O103, O91, O145 and O111 that, after O157, are the serotypes most 
frequently causing human infections in Europe (Anonymous, 2007).  
This thesis focuses on VTEC O157:H7 affecting cattle and pigs in Sweden 
and the importance of these species as sources of human EHEC infections. 
However, the importance of other serotypes should not be underestimated.   16
1.4  VTEC O157 (Seropathotype A) 
VTEC O157:H7 is the prototype bacterium for EHEC and is the serotype 
most frequently isolated from outbreaks and severe human disease 
worldwide (Karmali et al., 2003). 
1.4.1  Non-sorbitol and sorbitol-fermenting VTEC O157 
In contrast to other E. coli strains, VTEC O157:H7 strains cannot rapidly 
ferment sorbitol, do not produce ß-glucuronidase and are generally, resistant 
to the antimicrobiological agent tellurite. These are all features that can be 
used to indentify VTEC O157:H7 strains. Due to their inability to rapidly 
ferment sorbitol, VTEC O157:H7 are often referred to as non-sorbitol-
fermenting (NSF) E. coli O157. However, some strains can ferment sorbitol 
rapidly within 24 h of incubation and these are referred to as sorbitol-
fermenting (SF) E. coli O157 (Karch & Bielaszewska, 2001).  
The SF VTEC O157:H- strains are non-motile due to a “12-p” deletion 
in the fliC gene (Monday et al., 2004), They produce ß-glucuronidase and 
carry vtx2 as their sole VT gene (Ammon et al., 1999). Furthermore, they are 
not tellurite-resistant, as they lack the ”tellurite adherence conferring island” 
(TAI) present in NSF VTEC O157:H7 (Karch & Bielaszewska, 2001; Tarr 
et al., 2000). Moreover, SF VTEC O157:H- have acquired specific adhesion 
factors, novel pili, encoded by spf that distinguish them from other E. coli, 
another feature that can be used to identify SF VTEC O157:H- (Friedrich et 
al., 2004). 
1.4.2  The genome of VTEC O157:H7 
Genome comparison studies have revealed a high degree of genomic 
diversity within the VTEC O157 population, which is attributed to many 
events of insertion/deletion and recombination of DNA. Most of these 
events seem to be prophage mediated or driven by other mechanisms of 
horizontal gene transfer (Ohnishi et al., 2002). 
Most VTEC O157:H7 strains carry a ~90 kb large plasmid, pO157 (often 
also referred to as the 60 MD plasmid). A similar but not identical plasmid, 
pSFO157, is found in SF VTEC O157:H- (Friedrich et al., 2004; Karch et 
al., 1993).  
The first two strains of VTEC O157:H7 that were whole genome 
sequenced were “EDL 933” (Perna et al., 2001) and “Sakai O157” (Hayashi 
et al., 2001). When all sequence data were compiled they revealed that both 
strains had a genome of ~5.5 Mb which was ~0.9 Mb larger than the earlier 
sequenced genome of the non-pathogenic K12 laboratory strain, “MG 
1655”. Apart from a common, highly conserved backbone of 4.1 Mb   17 
(shared by all three strains), the VTEC O157:H7 strains  had about 1.34 
million additional base pairs that not could be found in K12. On the other 
hand, about half a million of the base pairs from the K12 genome were 
missing in both sequenced VTEC O157:H7 strains. The additional “VTEC 
O157:H7-specific” 1.34 Mb were organized into several hundred “gene 
cassettes”, O-islands or S-loops varying in size from 19 bp up to more than 
15 kb. Prophage and prophage-like elements were abundant in these gene 
cassettes and about two-thirds of the Sakai O157 genome consisted of such 
elements (Ohnishi et al., 2002). 
1.4.3  Evolution of VTEC O157 
In 1993 Whitham and colleagues suggested that E. coli O55:H7, an EPEC 
serotype known to cause infantile diarrhea, could be the ancestor of VTEC 
O157:H7 (Whittam et al., 1993). Feng and colleagues elaborated on this 
hypothesis and in 1998 proposed a stepwise evolution model for VTEC 
O157:H7 with O55:H7 as its progenitor (Feng et al., 1998). A recent study 
based on differences in single nucleotide polymorphisms (SNPs), located in 
the stable part of the genome, takes this evolution model even further (see 
Fig. 2) (Leopold et al., 2009). In that study the authors even estimated the 
time spans in which the different subtypes evolved. For instance the SF 
O157:H- strain, commonly found among HUS cases in Germany 
(Subgroup B in Fig. 2) is believed to have emerged ~7000 years ago and 
Cluster 1 of Subgroup C strains, found among humans e.g. the American 
”spinach outbreak strain” (Manning et al., 2008) might have emerged 
~3,000 years ago.  
Subgroup A
SF O55:H7
Extinct
ancestor
SF O157:H7
VT2
Subgroup C
Cluster 1
NSF O157:H7
VT2
Subgroup B
SF O157:H-
VT2
Subgroup C
Cluster 2
NSF O157:H7
VT2
Subgroup C
Cluster 3
NSF O157:H7
VT1+VT2
Acquisition of
•O157 antigen, rbfO157
• Large plasmid
•VT 2 prophage
Acquisition of
• TAI genomic 
island (tellurite
resistence)
Loss of
•Sorbitol
fermentation
•ß-glucuronidase
activity
Acquisition of
•VT2 prophage
inserted in wrbA
Acquisition of
•VT 1 prophage
Loss of motility
 
Figure 2. Proposed stepwise evolution model for VTEC O157:H7 from E. coli O55:H7. 
(Modified from Leopold et al., 2009)   18
1.4.4  VTEC O157:H7 in a historical perspective 
As early as from the 1960s, publications from Argentina have described 
HUS cases in children preceded by a period of diarrhea (Gianantonio et al., 
1964; Gianantonio et al., 1962). In an article published in 1972, 
Gianantonio and colleagues reviewed 678 Argentinean HUS cases in 
children from 1957 to 1972 where no etiological agent could be identified 
(Gianantonio et al., 1973).  
VTEC was first described in Canada in the late 1970s by Konowalchuk 
and colleagues (Konowalchuk et al., 1977). In 1982 it was first demonstrated 
that E. coli strains could produce a “shiga like toxin” (O'Brien et al., 1982). 
A year later, O’Brien and Laveck managed to purify verotoxin from an E. 
coli strain, concluding that the toxin was both structurally and antigenically 
similar to the Shiga toxin produced by Shigella dysenteriae type 1, and 
therefore described the new toxin as a “shiga like toxin” (O'Brien & 
LaVeck, 1983; O'Brien et al., 1983).  
In 1982 Riley and colleagues were able to link a multistate food-born 
outbreak in USA (involving hamburger patties) to patients with bloody 
diarrhea (HC). A rare serotype “E. coli O157:H7” was isolated from stool 
samples and the strain was later shown to produce VT (Riley et al., 1983). 
The same year, Karmali and colleagues established that HUS could be 
caused by VTEC O157:H7 and VTEC of other serotypes (Karmali et al., 
1983a; Karmali et al., 1983b). 
Following the observation that production of VT was linked to HUS, it 
could also be confirmed that HUS cases among children in Argentina were 
caused by VTEC (Novillo et al., 1988).  
1.5  Virulence factors of VTEC O157 in humans 
1.5.1  Verotoxin (VT) 
Verotoxins are the main virulence factor of EHEC. The name derives from 
their specific cytotoxicity to Vero cells (African green monkey kidney cells). 
VTs belong to a family of AB5 toxins, characterized by a single 
enzymatically active A subunit ~32kDa linked to a pentamer of five 
identical receptor-binding B subunits, each ~7.7kDa (see Fig. 3). 
Based on toxin-neutralization and nucleotide sequence analyses the 
verotoxins are classified in two major groups, VT1 and VT2, showing 
approximately 60% nucleotide sequence identity. These two major groups 
can be further divided into several variants. VTEC strains may harbour a   19 
single VT alone or possess several different (or similar) variants in 
combinations (reviewed by Müthing et al., 2009). 
 
Figure 3.  Schematic (A) and (B) crystallographic structure of verotoxin. The cleavage site for 
Furin is indicated with an arrow in (A). (Reproduced with the permission of Toxicon, 
Sandvig, 2001) 
Generally, VT2 has been more closely associated with severe disease and 
HUS, than has VT1 (Jenkins et al., 2003; Boerlin et al., 1999; Ostroff et al., 
1989). VT2 has also proved to be 1000 times more potent as an agent toxic 
to human renal endothelial cells, than VT1 (Louise & Obrig, 1995).  
VTs are encoded by temperate phages 
VTs are encoded by a number of heterogeneous temperate lambdoid phages 
that follow the lysogenic pathway and are inserted as prophages at specific 
insertion sites in the bacterial genome (reviewed by Allison, 2007). VTEC 
O157:H7 can carry several different phages and at least five different 
insertions sites have been described, whereof yehV and wrbA are those most 
commonly occupied (Serra-Moreno et al., 2007). 
Events that provoke the bacterial SOS response, such as exposure to UV 
light or antibiotics, lead to induction of the phage’s lytic cycle. The 
prophage is then excised and the bacterium starts to produce numerous 
phage particles and VT. This is followed by cell lysis whereby the phage 
particles and VT are released (Zhang et al., 2000; Muhldorfer et al., 1996). 
The phage particles released can also transduce other phage-sensitive 
bacteria in the gut, thus increasing the number of bacteria producing VT 
(Gamage et al., 2003).  
Furthermore, excision of integrated phages can take place without lysis of 
bacterial cells. For instance HUS patients can shed non-VTEC strains 
identical to the disease-causing EHEC strains, the only difference being 
absence of VT (Bielaszewska et al., 2007). It has also been demonstrated that   20
identical VT-phages can be present at different insertion sites in strains from 
human outbreaks, indicating that the phages can move between different 
insertion sites (Bielaszewska et al., 2006b). 
Mode of action 
The pentameric B unit of the VTs binds specifically to glycolipid receptors, 
Gb3 (globotriaosylceramide) or Gb4 (globotetraosylceramide), that are 
expressed on the cell surface by a variety of epithelial and endothelial cells 
(Gb4 is preferred by subgroup VT2e whereas all other VTs prefer Gb3; see 
below) (Lingwood et al., 1998). After attachment the toxin is internalized 
into the cell by receptor-mediated endocytosis (Römer et al., 2007). The 
toxin-receptorcomplex is transported via the trans-Golgi network to the 
endoplasmatic reticulum (ER) (Sandvig et al., 1992). Near the nuclear 
membrane the ~32kDa Subunit A is cleaved by a protease, furin, into a 
catalytically active A1 fragment and an A2 fragment (Garred et al., 1995). 
The A1 fragment is released into the cytosol where it exerts tRNA N-
glycosidase activity that removes an adenine moiety from 28S rRNA in the 
eukaryotic 60S ribosomal subunit (Endo et al., 1988). This modification 
inhibits protein synthesis and leads to cell death, as the acceptor site for 
aminoacyl-tRNA is blocked. There are also VT-resistant cells, in which VT 
is engulfed and rendered ineffective by lysosomes (Hoey et al., 2003).  
In addition to the cytotoxic effect, VT can induce apoptosis, 
programmed cell death, characterized by DNA fragmentation, cell 
shrinkage, membrane blebbing and condensation of nuclear chromatin. This 
is mediated via an independent pathway regulated by proteins from the 
BcL-2 family (Jones et al., 2000; Suzuki et al., 2000). 
It has also been shown in renal carcinoma-derived cells that the specific 
binding of the B subunit of VT1 to Gb3 in itself produces intracellular 
signals which remodel cytoskeletal organizing proteins (Takenouchi et al., 
2004).  
Furthermore, VTs stimulate epithelial cells and a variety of non-
endothelial cells to secrete inflammatory mediators (cytokines, chemokines) 
that induce a pro-inflammatory response exaberating the detrimental effects 
of VTs on endothelial cells (reviewed by Naylor et al., 2005a).  
Variants of VT1 and VT2 
The two major groups, VT1 and VT2, can be subdivided into variants. The 
nomenclature is not conclusive and new variants of VT are constantly being 
described. The VT1 group has three variants: VT1, VT1c and VT1d 
(reviewed by Müthing et al., 2009). The VT2 group is comparatively more   21 
heterogeneous and can be divided into seven variants: VT2, VT2b, VT2c, 
VT2d, VT2e, Vt2f and VT2g (reviewed by Persson et al., 2007).  
The VT variants found in VTEC O157:H7 are VT1, VT2 and VT2c; all 
have been implicated in HUS cases, although VT2 is the one most closely 
associated with severe disease, especially among children < 5 years old 
(Kawano et al., 2008; Persson et al., 2007; Friedrich et al., 2002).  
The other VT variants are found in non-O157 VTEC strains and are 
rarely implicated in severe human disease, with the exception of a particular 
variant of VT2d, VT2dactivatable   which has been associated with bloody 
diarrhea and HUS (Bielaszewska et al., 2006a). Variant VT2e binds 
specifically to Gb4 and is associated with oedema disease in swine (Fan et al., 
2000; Bertschinger & Gyles, 1994) while the VT2f variant is associated with 
pigeons (Morabito et al., 2001).  
1.5.2  The LEE- mediated type III secretion system (TTSS)  
EHEC and EPEC adhere to enterocytes by attaching and effacing lesions 
(A/E lesions). These are characterized by localized destruction of brush 
border microvilli and intimate attachment to the plasma membrane of host 
epithelial cells. The bacteria also induce actin polymerization and 
rearrangement of the cytoskeletal architecture in the host cells, a mechanism 
that anchors the bacterium on pedestals securely cupped by the host cell.  
These events are mediated by a type III secretion system (TTSS). The major 
feature of TTSS is translocation of a variety of virulence factors from within 
the bacterium into the host cell via a filamentous needle complex (see Fig. 
4). The bacterium translocates its own receptor Tir (transmembrane intimin 
receptor) which is inserted into the host cell’s plasma membrane where it 
acts as an adhesion receptor for intimin, a bacterial outer membrane protein 
encoded by eaeA (see Fig. 5). The intimin–Tir interaction mediates intimate 
attachment for all bacteria that induce A/E lesions (reviewed by Garmendia 
et al., 2005). Several different intimin types have been described and named 
after the Greek alphabet. Intimin-γ, the type associated with VTEC 
O157:H7, has a tissue specificity for follicle-associated epithelium overlaying 
Peyers´s patches (Phillips et al., 2000). 
In addition to Tir, a subset of Type III effector proteins e.g. Map, EspF, 
EspG, EspH, EspB and sepZ, translocate into the host cell where they elicit 
a variety of reactions resulting in diarrhea and transmigration of acute 
inflammatory cells to the infection site (reviewed by Garmendia et al., 
2005).  
The structure and different components forming the filamentous needle 
complex (NC) are illustrated in Fig. 4. Beside its function as a syringe-like   22
“hollow needle”, the mature EspA filament is also an important adhesion 
factor establishing a transient link between bacterium and host cell. After 
translocation of effector proteins, the whole needle complex is removed 
from the bacterial cell surface. This i s  n e c e s s a r y  t o  m a k e  r o o m  f o r  t h e  
intimate bacterial attachment between intimin and Tir that is essential for 
the A/E lesions (reviewed by Garmendia et al., 2005)  
 
Figure 4. Schematic representation of the EPEC/EHEC type III secretion apparatus. The 
basal body of the TTSS is composed of the secretin EscC, the inner membrane proteins 
EscR, EscS, EscT, EscU, and EscV, and the EscJ lipoprotein which connects the inner and 
outer membrane ring structures. EscF constitutes the needle structure, whereas EspA subunits 
polymerize to form the EspA filament. EspB and EspD form the translocation pore in the 
host cell plasma membrane, connecting the bacteria with the eukaryotic cell via EspA 
filaments. The cytoplasmic ATPase EscN provides the system with energy by hydrolyzing 
ATP molecules into ADP. SepD and SepL have been represented as cytoplasmic components 
of the TTSS. (Reproduced with the permission of Infection and Immunity, Garmendia et al., 
2005)   23 
The proteins involved in A/E lesions are encoded by a large pathogenicity 
island called locus of enterocyte effacement (LEE). LEE is organized in five 
operons which encode regulators, structural components, chaperones and 
effector proteins involved in the TTSS.  Many effector proteins identified as 
EHEC virulence factors are also encoded outside LEE but still utilize the 
TTSS NC apparatus for translocation into the host cell (reviewed by 
Garmendia et al., 2005).  
LEE gene expression is regulated by complex mechanisms dependent on, 
among other things, cell contact and environmental conditions, e.g. levels of 
NaHCO3. Expression is also regulated via quorum sensing (QS) which can 
be described as a communication system amongst bacteria via hormone-like 
compounds, auto inducers, that regulate bacterial gene expression (Pacheco 
& Sperandio, 2009; Sperandio et al., 2003). 
VTEC O157:H7 
Intimin
Tir
TccP IRSK N-WASP Arp2/3 Actin
Plasma 
membrane
Actin polymerization
 
Figure 5. Attachment of intimin to the translocated receptor, Tir, which inserts into the host 
cell’s plasma membrane. TccP, IRSK, N-WASP Arp2/3 and actin are different components 
involved in the actin polymerization process which “anchors” the bacteria to the host cell. 
(adapted from Frankel & Phillips, 2008) 
1.5.3  Non-LEE associated virulence factors 
Many putative virulence factors have been described for VTEC O157:H7 
and new effector proteins are continually being identified. Selected 
virulence factors encoded outside the LEE pathogenicity island are listed in 
Table 4.    24
Table 4. Virulence factors encoded by virulence plasmid pO157 
Effector Functions   
EHEC-Haemolysin  RTX toxin, induces lysis of erythrocytes 
a 
KatP  Catalase peroxidase activity, can protect from oxidative stress 
exerted by host immune cells  
b 
EspP  Auto transported serine protease; proteolytic activity for 
coagulation factor V, expresses toxicity to vero cells, may promote 
mucosal haemorrhage and induces cell cytotoxicity 
c 
ToxB  Adherence factor, promotes adherence to epithelial cells and 
production/secretion of TTSS proteins (EspA, EspB and Tir), may 
also inhibit lymphocyte activation 
d 
a
(Schmidt et al., 1995) 
b
(Brunder et al., 1996) 
c
(Brunder et al., 1997; Djafari et al., 1997) 
d 
(Tatsuno et al., 2001)
 
Table 5. Non-LEE virulence factors encoded on the chromosome 
Effector Functions   
Iha   irgA, adherence-conferring protein, membrane protein acts as an 
adherence factor to epithelial cells, found in VTEC O157:H7 but 
not in SF VTEC O157:H-. 
e 
Efa1  EHEC factor for adherence, adhesion factor; also inhibits  
proliferation of human lymphocytes, may modulate mucosal 
immune responses in cattle 
f 
CDT-V  Cytolethal distending toxin, disrupts cell cycle and blocks mitosis in 
G2/M phase, found in 6% of VTEC O157:H7 and in 87% SF 
VTEC O157:H- 
g 
TccP/EspFu  Tir-cytoskeleton coupling protein; associates with Tir, binds  
N-WASP and stimulates actin polymerization, seen in pedestal 
formation (see Fig 5) 
h 
Esp J  E. coli secreted protein, inhibits macrophage opsonophagocytosis 
g 
e
(Tarr et al., 2000) 
f
(Stevens et al., 2002)
 g
(Bielaszewska et al., 2005) 
h
(Garmendia et al., 2004)  
g
(Marches et al., 2008)
 
1.5.4  Variance in virulence among VTEC O157 strains 
Based on genomic differences identified by octamer-based genome scanning 
(OBGS) (Kim et al., 1999), lineage-specific polymorphism assay (LSPA) 
(Yang et al., 2004) and micro array based comparative genomic hybrid-
ization (mCGH) (Zhang et al., 2007), VTEC O157:H7 strains have been 
categorized in three lineages. Lineage I comprises strains commonly isolated 
from both cattle and humans, lineage II comprises strains isolated primarily 
from cattle whereas the third lineage, I/II, has not been strictly characterized 
regarding host distribution. The fact that lineage II strains are seldom   25 
isolated from humans implies that these strains are less virulent for humans 
or ineffectively transmitted to humans from bovine sources (Kim et al., 
1999). Furthermore, it has been shown that strains from lineage I and 
lineage I/II produce significantly more VT2 than strains from lineage II and 
that this is due to genetic differences in the prophages carrying the VT2 
genes from the different lineages (Zhang et al., 2009). 
A recent in silico study comprising six different DNA typing methods 
(Laing et al., 2009) reported that lineage I/II strains belonged to a putative 
hyper-virulent clade of strains, called clade 8 (Manning et al., 2008). By 
developing a single-nucleotide polymorphism (SNP) typing system, 
Manning and colleagues were able to distribute 519 VTEC O157:H7 strains 
into nine evolutionary clades. Using clinical data from isolated strains they 
found that patients infected with VTEC O157:H7 strains from one of the 
clades, clade 8, were seven times more likely to develop severe disease. 
Moreover, these patients were more likely to be younger (ages 0-18) than 
patients infected with strains from the other clades. Clinical outbreak data 
also revealed that clade 8 strains led to remarkably high rates of 
hospitalization (average 63%) and HUS (average 13%) compared with other 
outbreak strains.  
A greater diversity of VT-encoding bacteriophage insertion sites has also 
been reported from VTEC O157:H7 strains isolated from cattle, than was 
found in isolates from humans (Besser et al., 2007). Other studies have 
reported higher concentrations of secreted TTSS-proteins encoded by LEE 
in VTEC O157 strains associated with disease, than in strains shed from 
cattle (Roe et al., 2004; Roe et al., 2003).  
SF VTEC O157:H- is also reportedly able to cause high rates of severe 
disease. In a Scottish outbreak in 2006, 10 (50%) of 20 cases with diarrhea 
progressed to HUS and in Germany the odds for developing HUS after SF 
VTEC O157:H- infection are estimated to 1:2 (reviewed by Rosser et al., 
2008). SF VTEC O157:H- is synonymous with subgroup B in Fig. 2. 
1.6  VTEC O157 in humans 
1.6.1  Disease in humans 
Clinical manifestations of VTEC O157:H7 vary from no symptoms at all 
(asymptomatic carriers), to mild watery diarrhea, bloody diarrhea, to severe 
complications such as haemolytic uraemic syndrome (HUS), thrombotic 
thrombocytopenic purpura (TTP) and even death (reviewed by Mead & 
Griffin, 1998). Figure 6 shows alternative clinical pathways for a patient 
clinically infected with VTEC O157:H7.   26
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Figure 6. Illustrating how an infection with VTEC O157:H7 can develop along alternative 
clinical pathways. Note that indications of time are approximative. (Adapted from Tarr et al., 
2005) 
The infectious dose of VTEC O157:H7 is very low, estimated to be <50 
(Tilden et al., 1996) or mere a few hundred bacteria (Bell et al., 1994). After 
a mean incubation period of 3 days (can vary from 1 to 8 days) infected 
humans develop watery diarrhea, vomiting (30-60% of cases) and abdominal 
pain with cramps. About 30% of patients have mild fever, usually observed 
in the early stages of the disease (reviewed by Mead & Griffin, 1998). About  
1-3 days after onset, over 70% of the patients develop bloody diarrhea 
(hemorrhagic colitis, HC) though lower frequencies have also been 
reported. The amount of blood in faeces varies from traces to almost 
entirely blood (reviewed by Tarr et al., 2005; and Mead & Griffin, 1998). 
Most patients recover spontaneously within a week of onset, whereas a 
small subset of cases progress to HUS or other complications. The 
proportion of patients who progress to severe bloody diarrhea and/or HUS 
varies for different strains of VTEC O157, as well as age and immunological 
status of the infected patient. In sporadic cases, 3-7% of cases progress into 
HUS whereas in specific outbreaks a HUS incidence of up to 20% has been 
reported (reviewed by Mead & Griffin, 1998). The risk that a child <10 
years old with a diagnosed VTEC O157:H7 infection will develop HUS is 
estimated to be about 15% (reviewed by Tarr et al., 2005). 
HUS occurs 5-13 days after the onset of diarrhea and is characterized by 
haemolytic anaemia with fragmented erythrocytes, thrombocytopenia and 
acute renal failure (reviewed by Karch et al., 2005). The syndrome can be   27 
life threatening and patients need to be hospitalized and given intensive care 
including intravenous fluid perfusions. About half of all HUS patients 
require dialysis, 80% need erythrocyte transfusions, while 3-5% succumb 
(reviewed by Tarr et al., 2005; and Mead & Griffin, 1998).  
Elderly persons also run a greater risk of developing HUS – or a 
condition resembling HUS, called TTP. This is more common in adults 
and, in addition to acute renal failure, is also characterized by fever and 
neurological symptoms such as lethargy, severe headache, convulsions and 
coma (reviewed by Paton & Paton, 1998). Other acute complications 
reported after VTEC O157:H7 infections are cardiac dysfunction, 
pancreatitis, stroke, rectal prolapse and colonic perforation with peritonitis 
(reviewed by Karch et al., 2005). 
A small subset of patients develop chronic renal sequelae or other 
sequelae such as diabetes mellitus, neurological disorders, hypertension and 
colonic strictures (reviewed by Karch et al., 2005). 
 
1.6.2  Pathophysiology in humans  
After ingestion, acid-resistance mechanisms of VTEC O157:H7 facilitates 
their survival through the low pH of the stomach (Palermo et al., 2009). 
The bacteiria becomes attached by adhesins to the epithelium in the colon 
(reviewed by Spears et al., 2006). Quorum sensing (QS) mechanisms 
probably up regulate expression of the bacterial genes needed for 
attachment, so that even small quantities of bacteria succeed in attaching 
(Pacheco & Sperandio, 2009). The bacteria colonize enterocytes via the 
TTSS pathway and A/E lesions are created (reviewed by Spears et al., 2006). 
VT and endotoxin (LPS) are released and absorbed across the gut 
epithelium. VT, LPS and possibly other virulence factors lead to an increase 
in proinflammatory cytokines from host cells and subsequent release of 
chemokines from inflammatory cells. The susceptibility for VT in the 
intestine microvascular endothelial cells is exacerbated by this 
proinflammatory response (reviewed by Palermo et al., 2009). VT and LPS 
activate thrombocytes, and the endothelial injuries, activation of the 
coagulation cascade and inhibition of fibrinolysis lead to formation of 
thrombi that occlude capillaries and small arterioles. The intestinal vascular 
injury leads to ischaemia and necrosis that, together with the inflammatory 
response, probably cause the bloody diarrhea (reviewed by Tarr et al., 2005).  
VT and LPS can also enter the bloodstream where, bound to poly-
morphonuclear leukocytes (VT) (Brigotti et al., 2008; te Loo et al., 2000) 
and thrombocytes (LPS), (Ståhl et al., 2006) they can reach the kidneys. In   28
the kidneys, Gb3 receptors are expressed on endothelial glomerular cells, 
mesangial and tubular epithelial cells. The proinflammatory response and 
actions of VT elicit a pronounced endothelial swelling and the 
prothrombotic mechanism leads to occlusion of small blood vessels in the 
glomeruli. By acting on renal tubular cells, VT induces apoptosis. When 
acting in combination, these mechanisms lead to thromobcytopenia and 
acute renal failure (reviewed by Tarr et al., 2005; and Proulx et al., 2001). 
The anaemia with fragmented erythrocytes, as seen in HUS, is caused by 
mechanical breakdown when the erythrocytes pass partly occluded blood 
vessels, and/or by oxidative damage (reviewed by Proulx et al., 2001).  
Another organ containing endothelial cells with Gb3 receptors are the 
brain where the VTs can cause endothelial damage and thrombotic disorders 
leading to neurological symptoms (reviewed by Proulx et al., 2001). 
 
1.6.3  Routes of transmission to humans 
In general, the different routes of transmission of VTEC O157:H7 to 
humans are via food or various items either directly or indirectly 
contaminated by ruminant faeces. As the infectious dose is very low the 
bacterium’s excellent capacity to survive over time in different 
environments is of decisive importance.  
 
Food-borne infections  
Contaminated food of bovine or ovine origin such as unprocessed meat, 
undercooked hamburgers, coldfermented sausages, unpasteurized milk, 
yoghurt and cheese made from unpasteurized milk are common causes of 
VTEC O157:H7 infections. Vegetables and fruit products e.g. unpasteurized 
apple juice, and also vegetables and salad ingredients such as lettuce, spinach, 
alfa alfa and radish sprouts, have also been associated with several outbreaks. 
These food products may have been contaminated by direct spreading of 
cattle manure on growing crops or indirectly via contaminated irrigation or 
processing water (Anonymous, 2006; Hussein & Sakuma, 2005).  
The largest known VTEC O157:H7 outbreak to date was caused by 
radish sprouts in Sakai City, Japan in 1996, where 6,000 mostly 
schoolchildren became ill and 1.2% of them developed HUS (Michino et 
al., 1999). In 1996, 522 people in Scotland were infected and 22 died after 
eating contaminated meat from a butcher’s shop (Cowden et al., 2001). 
Water in private wells contaminated by grazing cattle is a common 
infection route of VTEC O157:H7 in Scotland (Strachan et al., 2006). In an   29 
outbreak in Walkerton, Ontario, Canada in 2000, 2,300 people became ill, 
28 developed HUS and 7 died after drinking municipal water contaminated 
with both Campylobacter jejuni and VTEC O157:H7 (Richards, 2005). For 
more details regarding foodstuffs as sources of infection, see publication 
from European  comisson healt & consumer protection directorate- general 
(Anonymous, 2003). 
In autumn 2002 there was a Swedish VTEC O157:H7 outbreak in the 
province of Skåne affecting 30 patients all of whom had consumed infected 
coldfermented sausage. Of these, 13 (43%) were hospitalized and 9 (30%) 
developed HUS (Sartz et al., 2007). Another outbreak occurred in 
southwest Sweden in the summer of 2005 where 135 cases, including 11 
(8%) HUS patients, proved culture-positive for VTEC O157:H7 after eating 
contaminated fresh lettuce (Söderström et al., 2008). 
 
Direct or indirect contact with animals 
There are numerous reports of cases where people have contracted an 
EHEC infection after visiting a farm where ruminants have been found 
shedding VTEC O157:H7. Often these farms are so-called “visiting farms” 
where children are allowed to meet and pet animals (Strachan et al., 2006; 
Crump et al., 2002; Lahti et al., 2002). Non-ruminant animals on these 
farms may also be transmitting VTEC O157:H7 infection after they have 
picked up the bacterium from ruminants (Pritchard et al., 2001). 
 
Exposure from environment 
Ruminants – especially cattle – can excrete high levels of VTEC O157:H7 
(>10
5  cfu/g) in faeces (Ogden et al., 2004; Strachan et al., 2001). The 
bacterium spreads to the environment via grazing ruminants or by direct 
spreading of infected manure on land. After heavy rainfall the bacterium can 
spread further in the environment by overland runoff.  
VTEC O157:H7 has a great capacity to survive for lengthy periods in 
manure, soil and water. Survival in bovine faeces ranges from 46-126 days 
(Fukushima et al., 1999) and up to 90 days in cattle slurry (McGee et al., 
2001). In water the bacterium can survive for 40 days at 21˚C and for > 70 
days at 5˚C (reviewed by Fremaux et al., 2008). In studies on manure 
amended soil, VTEC O157:H7 persisted for 25 to as long as 231 days, 
depending on experimental environmental conditions and inoculum levels 
(reviewed by Fremaux et al., 2008).   30
Studies in Canada, Germany and Scotland have concluded that people 
living in rural areas with high cattle density run a higher risk of contracting 
VTEC O157 infections than people living in an urban environment (Frank 
et al., 2008; Strachan et al., 2006; Michel et al., 1999). Swedish and Danish 
studies have shown that the risk for children ≤5 years old of contracting 
VTEC infection increases, the closer they live to a cattle farm (Ethelberg et 
al., 2009; Rydevik et al., 2008). 
 
Person to person infections 
The very low infectious dose facilitates spreading of VTEC O157:H7 
infection from person to person via the faecal–oral route. Deficient hygiene 
after toilet visits enhances this transmission route which is common among 
family members, carers and in institutional settings such as day-care centres 
and homes for the elderly. 
In outbreaks, several routes of transmission are often involved e.g. in 
food-borne outbreaks person to person spread is common between patients 
who have eaten infected food. 
 
1.6.4  Epidemiology of infection in humans 
VTEC infections show a seasonal variation, with an increase in human cases 
during summer and early autumn (PEN, 2006a). The incidence peaks in 
children ≤ 4 years, but falls rapidly with increasing age (PEN, 2006a). Severe 
complications are more commonly seen in children (HUS) and elderly 
patients (Both HUS and TTP) (Karmali et al., 2009; PEN, 2006a) whereas 
asymptomatic carriers are more common in the age groups in-between. 
Most cases are sporadic, although large outbreaks do occur (reviewed by 
Strachan et al., 2006; reviewed by Rangel et al., 2005). 
Reported incidences of human VTEC infections and VTEC serotypes 
vary between different parts of the world. VTEC O157:H7 is the 
predominant serotype in north America and Japan (Griffin et al., 2009; 
Watanabe et al., 2009; Anonymous, 1997a). Argentina has the highest global 
incidence rate of HUS in children ≤ 5 years old (15 per 100,000), the 
predominant etiological agent being VTEC O157:H7 (Rivas, 2009). 
Although VTEC O157:H7 is not the predominant serotype in all 
European countries it is still the one most commonly associated with severe 
disease in Europe (Anonymous, 2009). Table 6 presents the countries 
having the highest incidence of VTEC in Europe in 2007.  
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Table 6. Reported incidence rate of human VTEC cases in 2007 for the top 6 countries in the EU and 
proportions attributed to VTEC O157 among those cases where the serotype was established 
Country Cases  per 
/100,000 (all 
serotypes) 
Proportion VTEC O157  
in reported cases when 
serotype was established  
Scotland 
1    4.9*   94% 
Sweden
2 2.9  ID  ** 
Denmark
2 2.9  16% 
Ireland
2 2.7  81% 
United Kingdom (including  Scotland)
2 1.9  98% 
Germany
2  1.1     ID*** 
* Scottish figures are for culture-positive VTEC strains only.   
** ID, Insufficient data. Only 46% of reported cases serotyped.*** Only 34% of reported cases serotyped  
1 (Personal communication Mary Locking, Health Protection, Scotland)  
2
(Anonymous, 2009)  
 
In Sweden, infection by VTEC O157:H7 has been a notifiable disease 
under the Communicable Disease Act since 1st January 1996. The 
notification system was expanded in July 2004 to include all serotypes of 
VTEC. Both clinical and subclinical cases are reported by both the analysing 
laboratories and the treating physicians.  
Before 1995, very few human cases of VTEC infection were reported, 
viz. between one and five cases annually, but after two consecutive VTEC 
O157:H7 outbreaks of probable food-borne origin in 1995-96 (Ziese et al., 
1996) there was an increase in reported cases. Fig. 7 illustrates the number of 
total and domestic reported VTEC cases in Sweden, 1997-2008. Note that 
the increased incidence seen since 2004 was due to all serotypes being 
included in the notification system (see above). 
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Figure 7. Reported VTEC cases, (total and domestic) in Sweden, 1997-2008 (Anonymous, 
1997b)   32
There is an obvious geographical variation in incidence between regions 
(see map Fig. 8). The province of Halland, in the southwest, has consistently 
had the highest incidence of domestic VTEC cases (mean incidence, 1997–
2008, 7.0 domestic cases /100,000 inhabitants) (Anonymous, 1997b) 
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Figure 8. Map illustrating geographical variation in calculated main incidence rates of human 
VTEC cases in Sweden during 1997-2008. Map made by Martin  Bergström, SVA   
(Source: Anonymous, 1997b)   33 
Since 2004, all serotypes of VTEC are notifiable, but serotyping is not 
performed on all of the reported VTEC isolates. However, according to 
estimates by the Swedish Institute for Infectious Disease Control (SMI), 
VTEC O157:H7 accounts for approximately half of all reported cases of 
VTEC. Furthermore, there is a specific predominant variant among the 
VTEC O157:H7 strains isolated from humans, defined as phage type 4 and 
having two different verotoxin variants, VT2 and VT2c. More than two-
thirds of the VTEC O157:H7 isolates from domestic cases during 2001-
2007 belonged to this specific variant (personal communication, Sven 
Löfdahl, SMI; Löfdahl, 2008) 
The most common serogroups in Sweden after O157 are O121, O26, 
and O103 (Löfdahl, 2008). 
Deaths caused by VTEC infection are uncommon in Sweden, though 
three children have succumbed since 1996: one 5-year-old boy with VTEC 
O26 in 2006, in 2008 one 8-year-old boy infected by SF O157:H- and a 2-
year-old girl infected with VTEC O157:H7 (PT4;Vtx2,Vxt2c) (Personal 
communication Sofie Ivarsson, SMI). 
 
 
 
1.7  VTEC O157:H7 in cattle and pigs 
1.7.1  Structure of the Swedish cattle population  
In 2008 the total cattle population in Sweden was estimated to approx. 
1,558,400 head (Anonymous, 2008) and registered herds numbered 25,847 
(see Table 7). The maps in Fig. 9 demonstrate cattle density and cattle herd 
density within different postal areas in Sweden in 2008. 
 
Table 7. Registered number of cattle herds in Sweden in 2008  
Type of herd  No. of premises  Proportion of 
total no. of premises 
Dairy   6,704  25.9% 
Suckler 11,661  45.1% 
Others 7,482  29.0% 
Total 25,847  100.0% 
(Source: Personal communication, Maria Nöremark, SVA) 
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Figure 9. Differences in cattle density, cattle > 1 years old, (left) and cattle herd density (right) 
within different postal code areas in Sweden in 2008. Maps made by Jenny Frössling, SVA. 
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1.7.2  VTEC O157:H7 in animals 
Cattle constitute the main reservoir for VTEC O157:H7, but sheep are also 
considered a significant source of infection in humans (reviewed by La 
Ragione et al., 2009). Furthermore, VTEC O157:H7 has been isolated from 
goats (Pritchard et al., 2000; Bielaszewska et al., 1997) and water buffalos 
(Conedera et al., 2004). Wild ruminants can also act as a potential reservoir; 
for instance VTEC O157:H7 has been isolated from wild deer (Renter et 
al., 2001). Occasionally, the bacterium has been isolated from non-ruminant 
species e.g. horse, dog, rabbit, seagull, starling, wild boar and rat (Jay et al., 
2007; Wetzel & LeJeune, 2006; reviewed by Naylor et al., 2005a; Cizek et 
al., 1999). These animals are not considered as hosts, but rather as vectors 
transiently colonized by the bacterium following contact with ruminant 
faeces (reviewed by Caprioli et al., 2005). 
1.7.3  Prevalence of VTEC O157:H7 in cattle 
Table 8 summarizes a subset of studies from different countries on the 
prevalence of VTEC O157 on cattle farms. It is difficult to compare results 
between the different countries due to differences in study design and 
methodology. However, in all the studies presented in Table 8 the faecal 
samples were analysed for VTEC O157:H7 with the sensitive immune 
magnetic separation (IMS) technique (see below under Considerations on 
Material and Methods). 
Table 8. Prevalence of VTEC O157 on farms 
Country Cattle  type  No. of  
farms 
% positive 
farms 
Reference 
USA (Midwest)  Ranch and feedlot cattle  29  72.0%  (Elder et al., 2000) 
Canada (Saskatchewan)  Feedlot cattle  20  60.0%  (Vidovic & Korber, 2006) 
USA (Ohio)  Dairy cattle  50  8.0%  (LeJeune et al., 2006) 
England&Wales   Dairy, suckler and fattener  75  38.7%  (Paiba et al., 2003) 
Scotland Finishing/store  cattle  481  18.9%  (Chase-Topping et al., 2007) 
Netherlands Dairy  cattle  678  7.2%  (Schouten et al., 2004) 
Spain Dairy  cattle  124  7.0%  (Oporto et al., 2008) 
 Beef  cattle  82  1.6%  (Oporto et al., 2008) 
Denmark Dairy  cattle  60  16.7  (Nielsen et al., 2002) 
Sweden   Dairy cattle  371  8.9%  (Paper II) 
Norway   Dairy cattle  50  0.0%  (LeJeune et al., 2006) 
 
In Sweden, a slaughterhouse prevalence survey of VTEC O157:H7 in 
slaughtered cattle was initiated in 1996. Between April 1996 and August   36
1997, 3,071 faecal samples were collected and analysed for VTEC O157:H7 
(Paper I). These slaughterhouse investigations proceeded as annual 
prevalence studies, where approximately 2,000 faecal samples were collected 
yearly during 1998-2002. It was then decided that the studies should be 
performed every third year, i.e. two more studies have since been 
conducted; one in 2005-06 (Boqvist et al., 2009) and one in 2008-09. In the 
latter two studies, in addition to the faecal samples, aural samples (piece of 
an ear, approx. 65 cm
2) were collected and analysed. The results from these 
studies are summarized in Table 9.  
Table 9.  Results Swedish prevalence studies for VTEC O157:H7 in slaughtered cattle 1996-2009 
Year No.  Faecal 
samples 
No. Positive 
feacal samples 
No. Ear  
samples  
No Positive 
ear samples 
1996-1997  3071  37   (1.2%)
A NP  NP 
1997-1998  2308  7     (0,3%)
B NP  NP 
1999  2057  14   (0.7%)
C NP  NP 
2000  2001  34   (1.7%)
A NP  NP 
2001  1998  26   (1.3%)
A   NP  NP 
2002  2032  29   (1.4%)
A NP  NP 
2005-2006  1758  60   (3.4%)
D  446  54    (12.1%) 
2008-2009  1993  65   (3.3%)
D  500  41     (8.2%) 
NP Not performed 
A 10 g of faeces analysed. Analyses performed at SVA. Pre-enrichment broth BPW  
B  1 g of faeces analysed. Analyses performed at regional laboratory. Pre-enrichment broth BPW 
C 10 g of faeces analysed. Analyses performed at regional laboratory. Pre-enrichment broth BPW 
D 10 g of faeces analysed. Analyses performed at SVA. Pre-enrichment broth mTSB + novobiocin 
 
Table 10 summarizes a subset of slaughterhouse studies performed in differ-
ent countries. All listed studies used IMS technology in their analyses. 
Table 10.  Prevalence of VTEC O157 in slaughtered cattle in other countries 
Country Year  No. faecal 
samples 
% positive  
samples 
Reference 
USA (Midwest)  1999  327  27.8%  (Elder et al., 2000) 
Netherlands 1995-1996  937  6.3%  (Heuvelink et al., 1998a) 
Great Britain  2003  2736  4.7%  (Milnes et al., 2008) 
Belgium 1998-1999  1281  6.2% (Tutenel et al., 2002) 
Poland 1999  551  0.7%  (Tutenel et al., 2002) 
Norway 1998-1999  1541  0.19%  (Johnsen et al., 2001) 
Finland 1997  1448  1.2%  (Lahti et al., 2001) 
Denmark  1999  227  3.0%  (Nielsen & Scheutz, 2002)   37 
 
1.7.4  Cattle farms implicated in human VTEC O157:H7 cases in Sweden 
In Sweden, in the period 1996 to 2008, 39 cattle farms (23 dairy farms, 15 
beef producers and 1 ”visitor farm”) 1 sheep farm and 1 goat farm have been 
associated with human VTEC O157:H7 cases. All these farms have been 
suspected as sources of human infections and collected ruminant faecal 
samples proved positive for VTEC O157:H7. In most cases the infected 
humans have been children who had been visiting farms or had drunk 
unpasteurized milk from dairy farms. There have also been cases where 
people permanently living on the farms have become severely ill. 
 
 
1.7.5  Epidemiology in cattle 
VTEC O157:H7 colonization in cattle 
Experimental infection with high doses of VTEC O157:H7 caused diarrhea, 
with A/E lesions in neonatal calves (Dean-Nystrom et al., 1997) and 
transient watery diarrhea in weaned calves (Brown et al., 1997). However, it 
is generally considered that cattle harbour the bacteria without expressing 
signs of disease (reviewed by Hancock et al., 2001).  
Gb3 receptors, the specific receptors for VT, are present in the 
proliferating crypt cells of bovine intestines but cannot be found in the 
vascular cells (Hoey et al., 2002). In addition, when VT is internalized into 
the bovine cells it is engulfed and rendered ineffective by lysosomes. This 
could explain the evident resistance of cattle to the systemic effects of VT 
(Hoey et al., 2003). 
Cattle become infected via the faecal-oral route and, under controlled 
conditions, very low infectious doses <300 cfu VTEC O157:H7 have 
induced shedding in calves (Besser et al., 2001). Sources of infection are 
considered to be direct contact with other cattle, contaminated water or 
feed, or exposure to the bacterium via the environment (reviewed by 
Chase-Topping et al., 2008). 
VTEC O157:H7 has been isolated throughout the whole bovine 
digestive tract from the oral cavity to the rectum, but it is more prevalent in 
the lower gastrointestinal tract (Grauke et al., 2002). It has also been isolated 
from bovine bile bladders (Jeong et al., 2007). 
However, the primary site of VTEC O157:H7 colonization in cattle is 
considered to be in a defined region in the terminal rectum (TR), 5 cm 
proximal of the rectal anal junction (RAJ). This region, also referred to as   38
the terminal mucosa (TM), is characterized by high density of lymphoid 
follicles (Naylor et al., 2003). In the TM the bacterium attaches and forms 
microcolonies (30-100 bacteria) and A/E lesions (Nart et al., 2008). 
Successful colonization has also been established directly by rectal swabs 
inoculated with VTEC O157:H7 (Naylor et al., 2007b; Sheng et al., 2006b).  
Following initial adhesion to bovine enterocytes by adhesins, such as 
fimbriae, outer membrane proteins and flagella, (Spears et al., 2006), 
colonization of VTEC O157:H7 in the TM is dependent on the TTSS 
system (Naylor et al., 2005b). It has been suggested that VTs potentiate 
VTEC colonization in cattle by modulating the bovine immune response, as 
VTs are able to block proliferation of bovine lymphocytes and are 
considered to have a significant effect on all main lymphocyte sub-
populations. It is also speculated that VTs may act on local B cells in the gut 
to hinder antibody production or secretion (Menge et al., 2003). 
Furthermore, it is reported that VT2 primes epithelial mouse cells for initial 
attachment by increasing expression of nucleolin on epithelial cell surfaces. 
Nucleolin, a multifunctional protein normally present in the nucleus, can 
act as an intimin receptor. VTEC may utilize this mechanism for initial 
attachment before the TTSS commences (Robinson et al., 2006). It has also 
been suggested that VTs potentiate colonization by VTEC in cattle by 
specifically targeting bovine crypt cells, thereby lowering their metabolism 
and reducing cell turnover in the intestinal epithelium (Hoey et al., 2002; 
Magnuson et al., 2000). 
Colonization in TM has been correlated to ”high shedders” (see below) 
(Cobbold et al., 2007; Low et al., 2005) and to long-term shedding (up to 
12 months) (Lim et al., 2007). 
Minor sites of VTEC O157:H7 carriage have also been identified in the 
bovine gastrointestinal system; the rumen, small intestine, proximal colon 
and in particular a region of lymphoid-rich tissue immediately distal to the 
ileocaecal valve (Nart et al., 2008). 
Hides from cattle can also be contaminated with VTEC O157:H7 and 
are considered to be a more important source of carcass contamination at 
slaughter than faecal excrement (Barkocy-Gallagher et al., 2003). 
 
VTEC O157:H7 shedding in cattle 
There is a wide variation, in both magnitude and duration, in faecal 
shedding of VTEC O157:H7. Cattle that do not get colonized shed the 
bacterium transiently for less than 1 week but, if they do become colonized 
they typically shed for a month on average, but no longer than 2 months.   39 
Very few animals may even shed for up to a year or longer (reviewed by 
Lim et al., 2007; and Davis et al., 2006).  
Artificially infected calves shed VTEC O157:H7 in greater numbers and 
for longer periods of time than adult cattle (Cray & Moon, 1995). Calves 
from weaning up to 12 months old are those that that most often shed 
VTEC O157:H7 (Paiba et al., 2003; Nielsen et al., 2002; Heuvelink et al., 
1998b). 
Shedding is often intermittent, and it has been reported that one and the 
same animal sampled just a few hours apart has shed in numbers varying 
from undetectable, up to ~10
3 cfu/g. However, there are also animals that 
can shed the bacterium both profusely and consistently for longer periods 
(Robinson et al., 2004).  
Most culture-positive animals (~75%) shed so few bacteria that VTEC 
O157:H7 can only be detected after IMS enrichment, viz. <100 cfu/g 
faeces, though a few may shed the bacteria more profusely, up to 1 x 
10
7cfu/g (Chase-Topping et al., 2007). Animals that shed VTEC O157:H7 
in numbers ≥10
3 or  ≥ 10
4/g faeces are referred to as “high-shedders” or 
“super-shedders” (reviewed by Chase-Topping et al., 2008). These animals 
are responsible for most of VTEC O157:H7 spread by cattle. In one 
Scottish slaughterhouse study, high-shedders yielded 9% of the positive 
samples, yet it was calculated that these animals accounted for >96% of all 
VTEC O157:H7 shed (Omisakin et al., 2003). 
 
Epidemiology in cattle herds 
VTEC O157:H7 positive faecal samples in sampled cattle herds are generally 
few, usually below 10% (reviewed by Hancock et al., 1998). According to 
Scottish studies the distribution in prevalence varies between 0 and 100 %, 
where most herds test negative or have a very low prevalence, while a small 
proportion of herds have a very high prevalence (Gunn et al., 2007; 
Matthews et al., 2006b). Interestingly, if a high-shedder is present in a herd 
the likelihood of finding many low shedding animals in the same herd is 
high (Chase-Topping et al., 2007). When cattle farms are sampled 
repeatedly over time the prevalence typically varies between the sampling 
occasions. A period with very low prevalence or no positive animals may be 
followed by a peak with many positive animals (Schouten et al., 2005; Synge 
et al., 2003; Hancock et al., 1997). Thus, repeated sampling, i.e. longitudinal 
studies, gives higher and more accurate prevalence estimates than studies 
based on a single sampling (Synge et al., 2003; Hancock et al., 1997). 
Likewise, individual animals cannot be classified as non-shedders when   40
based on a single sampling occasion, as shedding may be low or intermittent 
(Robinson et al., 2004; Garber et al., 1995). 
Statistic modelling based on data from Scottish field studies suggests that 
the observed variable distribution of prevalence at farm level (i.e. sporadic 
shedding by animals, occasional high prevalence and periods of apparent 
absence) is best explained by a model where a small proportion of animals 
with high excretion (high-shedders) infect the other cattle (Matthews et al., 
2006a; Matthews et al., 2006b).  
Greater numbers of cattle seem to shed VTEC O157:H7 during the 
warmer season than in wintertime and shedding seems to peak in late 
summer (Schouten et al., 2005; Barkocy-Gallagher et al., 2003; Paiba et al., 
2003). It is speculated that this phenomenon might be connected with day 
length and/or seasonal hormones (Edrington et al., 2007). Studies have 
shown that housing of animals is a risk factor for shedding of VTEC 
O157:H7 (Gunn et al., 2007; Synge et al., 2003), while keeping animals on 
pasture seems to reduce the prevalence (Jonsson et al., 2001). 
The bacterium thrives in the farm environment (Randall et al., 1999) and 
in one longitudinal study the same strain was shown to persist for more than 
2 years on the farm (Shere et al., 1998) where it could be isolated from 
birds, flies, from feed and drinking water. VTEC O157:H7 has also been 
isolated from rats (Cizek et al., 1999), indicating that rodents can function as 
vectors of transmission.  
In an American study, VTEC O157:H7 was found in 2.9% of house flies 
sampled from feedlot feed bunks (Alam & Zurek, 2004) and VTEC 
O157:H7 counts in house flies ranged from 3.0 x 10
1 to 1.5 10
5  cfu. 
Moreover, it has been shown that calves exposed to VTEC O157:H7 
positive house flies start shedding the bacterium within a day after exposure 
(Ahmad et al., 2007). 
Contaminated water has under experimental conditions successfully 
infected cattle (Shere et al., 2002) and the bacterium has been shown to 
survive for long periods (up to 245 days) in water-trough sediment. Thus, 
troughs can serve as a long-term reservoir for infection (LeJeune et al., 
2001). Furthermore, transmission of VTEC O157:H7 between herds of 
grazing cattle can occur if the cattle share water-courses e.g. rivers and lakes 
(LeJeune et al., 2001; Jackson et al., 1998). 
A subset of reported risk-factors, other than the above-mentioned, for 
cattle shedding VTEC O157 on farms, is listed in Table 11. 
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Table 11. Reported risk-factors for cattle shedding VTEC O157  
Risk-factor Reference 
Introduction of new cattle in herd   (Schouten et al., 2004; Nielsen et al., 2002; Wilson et al., 
1998) 
Grouping of calves    (Cobbold & Desmarchelier, 2002; Garber et al., 1995) 
Shared buckets and bottles for calves  
without washing and rinsing 
(Garber et al., 1995) 
High cattle density in feedlots  (Vidovic & Korber, 2006) 
Number of animals in a group  (Ellis-Iversen et al., 2007) 
Group housed in pens with wet bedding  (Ellis-Iversen et al., 2007) 
Movement of calves/animals in herds  (Chase-Topping et al., 2007; Rugbjerg et al., 2003) 
Stress (i.e. movement and weaning)  (Chase-Topping et al., 2007) 
Spreading of cattle slurry on pasture land  (Gunn et al., 2007; Hancock et al., 1994) 
Presence of wild geese (if animals are grazing)  (Synge et al., 2003) 
Presence of pig at farm  (Paper II, Cernicchiaro et al., 2009; Gunn et al., 2007; 
Schouten et al., 2004) 
Use of corn silage during winter  (Cernicchiaro et al., 2009) 
 
1.7.6  Prevalence in pigs 
Table 12 summarizes results from studies performed on slaughtered pigs. 
Table 12. Prevalence of VTEC O157:H7 in slaughtered pigs  
Country  Sampled material  No. of  
samples 
% pos. 
samples 
Reference 
The Netherlands  Faecal samples  142  1.2%  (Heuvelink et al., 1999) 
Norway  Faecal  samples 1996 0.1% (Johnsen et al., 2001) 
Great Britain  Faecal samples  2060  0.3%  (Milnes et al., 2008) 
Sweden  Faecal  samples 2446 0.1% (Paper  III) 
Italy  Faecal samples   150  0,7%  (Bonardi et al., 2003) 
USA  Faecal samples   306  2.0%  (Feder et al., 2003) 
Japan Rectal  swabs  221  1.4%  (Nakazawa & Akiba, 1999) 
Chile Faecal  samples  120  10.8%  (Borie et al., 1997) 
 
 
1.7.7  Pigs as a source for human VTEC O157:H7 cases 
Pork salami (only meat from pigs) was reported as the source of an Italian 
family outbreak of VTEC O157:H7 in 1994 where two adults contracted 
bloody diarrhea (Conedera et al., 2007). In a large American outbreak in 
2006 caused by spinach, it was concluded that wild boars had contaminated   42
the spinach. Strains matching the outbreak strain were isolated in faecal 
samples from wild boars that had invaded the crop fields (Jay et al., 2007).  
In Sweden, four farms that kept both ruminants and pigs were linked to 
human cases and VTEC O157:H7 was isolated from pigs on two of these 
farms. On both farms, however, ruminants sampled at the same time also 
yielded positive samples and they were deemed to be the primary source of 
infection. 
 
1.7.8  Epidemiology in pigs 
E. coli strains of serotype O157 that are enterotoxin producing (ETEC 
O157) can be isolated from both healthy pigs and pigs with postweaning 
diarrhea (Hampson, 1994). These other pathogenic E. coli O157 are 
distantly related to VTEC O157, and have a separate evolutionary pathway 
(Whittam et al., 1993). 
Artificial infection of neonatal piglets with high doses of VTEC 
O157:H7 has induced severe disease and A/E lesions (Dean-Nystrom et al., 
2000). However, older pigs do not become clinically ill or exhibit any 
pathological changes following VTEC O157:H7 infection.  
Experimental studies have shown that pigs have no innate resistance to 
colonization and can serve as a reservoir host, under suitable conditions. 
Three-month-old pigs have under experimental conditions been colonized 
after receiving an infectious dose of 10
10 cfu and shed the bacterium for up 
to 2 months. (Booher et al., 2002). Furthermore, it has been demonstrated 
that in contrast to ruminants, intimin is not necessary for persistent 
colonization in pigs (Jordan et al., 2005). Pigs can transmit infection to other 
pigs if they share the same pen or if they have nose to nose contact and the 
infectious dose has under experimental conditions been estimated to approx. 
6 x 10
3 cfu (Cornick & Vukhac, 2008; Cornick & Helgerson, 2004). 
1.7.9  Control options for VTEC O157:H7 in animals 
Management routines 
Management routines that counteract risk factors mentioned in the section 
above, “epidemiology in cattle herds”, may be of interest to reduce the risk 
of shedding in cattle. However, few scientific studies have evaluated such 
routines. 
A British study on young cattle demonstrated that a combined 
intervention package of management routines, applied over 4½ months, 
significantly reduced the level of VTEC O157:H7 shedding. The package 
consisted of measures such as using designated boot-dips and overcoats,   43 
keeping animals in the same group and ensuring dry bedding. The two 
measures of greatest importance were keeping young cattle in the same 
group throughout rearing, without introducing new animals, and ensuring 
constantly dry bedding. There was also weak evidence that not procuring 
new stock for the herd and avoiding direct contact with cattle from other 
farms were routines that reduced levels of shedding (Ellis-Iversen et al., 
2008). 
Using sand instead of sawdust for bedding purposes has been found to 
lower the prevalence in dairy cows (Lejeune & Kauffman, 2005). Swedish 
field trials have indicated that addition of slaked lime to bedding materials 
can also reduce shedding of VTEC O157:H7 (unpublished data)  
Calves aged 1-4 months have been reported to be less likely to become 
infected if they had suckled colostrum or stayed > 2 days with their mother 
(Rugbjerg et al., 2003). 
Feed control  
Studies on feed composition and faecal shedding of VTEC O157:H7 in 
cattle have presented contradictory results. It has been suggested that a 
grain-rich diet could induce VTEC acid resistance in the rumen and that 
this would favour survival of VTEC O157:H7. This mechanism should lead 
to increased faecal shedding by cattle that are fed a grain diet compared with 
cattle fed a forage-based diet (Diez-Gonzalez et al., 1998). Some studies 
support this hypothesis (Boukhors et al., 2002; Tkalcic et al., 2000), while 
others show that forage-fed cattle shed VTEC O157:H7 for longer periods 
than grain-fed animals (Midgley & Desmarchelier, 2001; Hovde et al., 
1999). There are yet other studies reporting no differences between the two 
feed categories (Grauke et al., 2002; Hancock et al., 1994). 
Several studies have reported that feeding cattle with barley may increase 
shedding of VTEC O157:H7, compared with feeding a corn-based diet 
(Berg et al., 2004; Boukhors et al., 2002). 
Several studies report that fasting increases the shedding of VTEC 
O157:H7 and makes calves more susceptible to colonization (Magnuson et 
al., 2000; Cray et al., 1998), while one study indicates that fasting has little 
effect on shedding (Harmon et al., 1999). 
It has been demonstrated under experimental conditions that VTEC 
O157:H7 can multiply in poorly fermented silage in numbers up to >10
6 
cfu/g (Fenlon & Wilson, 2000) but does not survive a good silage 
fermentation process (Byrne et al., 2002). Furthermore, inoculation of lactic 
acid-producing bacteria in ensilage hastens elimination of VTEC O157:H7 
(Bach et al., 2002).   44
Probiotics 
Probiotics can be defined as “Live microbial feed supplements which 
beneficially affect the host animal by improving its intestinal microbiological 
balance” (Fuller, 1989). Another term used in the USA for probiotics 
included in feed products for animals is direct-fed-microbials (DFD) (Elam 
et al., 2003). 
It has been proved experimentally that feeding cattle with specific E. coli 
strains that produce colicins (proteins that specifically target E. coli) can 
reduce shedding of VTEC O157:H7 (Schamberger et al., 2004; Tkalcic et 
al., 2003). 
Numerous lactobacillus strains have also been tested regarding their 
potential to reduce shedding of VTEC O157:H7 in cattle. Their 
effectiveness varied widely between different lactobacillus strains, even 
within the same species (Wilderdyke et al., 2004). The strain proven most 
effective to reduce shedding of VTEC O157:H7 in cattle is a specific 
Lactobacillus acidophilus strain called Lactobacillus acidophilus NP51. This strain 
has been proved in several American studies on feedlot cattle to reduce 
shedding of VTEC O157:H7 by up to 50%, where the maximum effect was 
achieved after the animals were fed the strain daily for 60 days (Younts-Dahl 
et al., 2005; Brashears et al., 2003; Elam et al., 2003). It has also been shown 
that culture-positive animals fed L. acidophilus N P 5 1  s h e d  f e w e r  V T E C  
O157:H7 than culture-positive animals not given this lacto-bacillus strain 
(Stephens et al., 2007). There is a commercially available product containing 
L. acidophilus NP51 which is commonly used in American feedlots to reduce 
VTEC O157:H7 shedding by cattle prior to slaughter (reviewed by 
Callaway et al., 2004a). This product also contains a Propionibacterium 
freudenreichii strain, included as a growth promoter (reviewed by Callaway et 
al., 2009). 
 
Phages 
There are lytic bacteriophages (viruses) that specifically target surface 
receptors on VTEC O157:H7. After binding to the bacterium they inject 
their DNA into the cell and convert the bacterium’s biosynthesis machinery 
to start producing new daughter phages. The latter are released when the 
host cell lyses and the released phages can infect new bacteria to repeat the 
process (reviewed by Johnson et al., 2008). 
Phages are plentiful in nature where they share the ecological niche with 
their bacterial host, which is why VTEC O157:H7 targeting phages can be 
isolated from cattle farms where VTEC O157:H7 is prevalent (Callaway et   45 
al., 2006). Phages have also been detected in feedlot water troughs and it has 
been shown that the prevalence of VTEC O157:H7 in faecal samples 
collected in feedlots is lower when phages are present than if they are absent 
(Niu et al., 2009). 
Bacteriophages targeting VTEC O157:H7 can be included in animal feed 
to reduce faecal shedding of VTEC O157:H7. Administration can be oral or 
rectal, but the oral route seems to be more effective (reviewed by Johnson et 
al., 2008). The bacteriophage preparations used in different studies often 
consist of a mixture of several different phages in order to prevent the 
development of resistance to the phages (Callaway et al., 2008b). In one 
study, bacteriophages had successfully eliminated VTEC O157:H7 in 
weaned calves 8 days after administration (Waddel et al., 2000) whereas 
other studies have reported only reduced shedding but not elimination in 
experimentally infected cattle (Rozema et al., 2009; Sheng et al., 2006a). 
Other additives in feed and water  
Orange peel and pulp, added at 2% of total volume, have in fermentation 
trials shown anti-VTEC O157:H7 activity, the efficacious component being 
inhibitory essential oils (Callaway et al., 2008a; Fisher & Phillips, 2006). In a 
study on 200 cattle, feeding brown seaweed (Ascophylum nodosum) led to a 
reduction in prevalence of faecal shedding from 35% to 10% (Braden et al., 
2004). 
Treating animals with the antibiotic neomycin sulphate has been 
demonstrated to reduce excretion of VTEC O157:H7 in cattle (Woerner et 
al., 2006). 
The chemical substance sodium chlorate is reduced to chlorite under 
anaerobic conditions by the enzyme nitrate reductase (Stewart, 1988) which 
is a bactericidal metabolite. When sodium chlorate was added to water or 
feed it was found to reduce VTEC O157:H7 populations in the intestines 
and faeces of cattle (Callaway et al., 2002) and pigs (Anderson et al., 2000). 
It has been suggested that sodium chlorate could be given as a supplement 
to cattle in the last meal as a pre-slaughter intervention and it has also been 
shown that the deleterious impact on ruminal fermentation is negligible 
(Anderson et al., 2000). 
Vaccines 
It has been demonstrated that infection with VTEC O157:H7 can elicit an 
immune response in cattle. For instance Naylor and colleagues found a 
protective humoral response against LPS and H7 in calves after a challenge 
dose of VTEC O157:H7. The authors also showed that this induced   46
protective immunity resulted in lower shedding levels when the same calves 
were re-inoculated (Naylor et al., 2007a).  
Human convalescent patients have been found to develop an antibody 
response to Tir, intimin, Esp A and EspB, proteins that are secreted by the 
type III secretion system (TTSS) after VTEC O157:H7 infections (Li et al., 
2000). It was also demonstrated that intimin (Cornick et al., 2002) and Tir 
(reviewed by Potter et al., 2004) are necessary for successful colonization in 
adult cattle. Furthermore, it has been shown that the LEE4 operon, which 
encodes several proteins essential for A/E lesions, is needed for colonization 
in the terminal rectum of cattle (Naylor et al., 2005b). 
Intimin-based vaccines have proved efficient in experimental trials in 
piglets (Dean-Nystrom et al., 2002) and mice (Judge et al., 2004). In a 
Canadian study, cattle were treated with a vaccine prepared from culture 
supernatant material with type III secreted proteins. Vaccinated cattle 
developed high antibody titres against type III secreted proteins such as Tir, 
EspA, EspB and EspD (Potter et al., 2004). This vaccine also significantly 
reduced the prevalence of VTEC O157:H7 in an experimental challenge 
model with 16 cattle and in a clinical trial including 192 steers (Potter et al., 
2004). However, when the same vaccine was tested in a large-scale study on 
nine Canadian feedlots it failed to produce any significant reduction in faecal 
shedding by vaccinated cattle (Van Donkersgoed et al., 2005). This backlash 
might have been due to a change of adjuvant that altered the vaccine’s 
immunogenicity. Nevertheless, with another adjuvant, used in subsequent 
feedlot studies with a two-dose regime, the vaccine reduced VTEC 
O157:H7 colonization in the terminal rectum by 92-98% in vaccinated 
feedlot cattle (Smith et al., 2009b; Peterson et al., 2007). Furthermore, in 
another feedlot study, vaccination significantly reduced shedding of VTEC 
O157:H7 among vaccinated cattle (4.8% positive samples) compared with 
unvaccinated cattle (11.5% positive), though, in this study no significant 
reduction in terminal rectum colonization could be proved in vaccinated 
animals (Smith et al., 2009a). Since December 2006 the vaccine used in 
those studies “Bioniche E. coli O157:H7” has been an authorized vaccine 
for field use in cattle feedlots in Canada. 
A Scottish study has revealed that systemic and mucosal immunization of 
cattle with purified H7 antigen leads to a humoral response and a delayed 
peak of VTEC O157:H7 shedding in calves. This indicates that H7 flagellin 
may be also a candidate to include in a systemic vaccine against VTEC 
O157:H7 (McNeilly et al., 2008). Furthermore, in a recent study, the same 
research group demonstrated that an experimental vaccine consisting of a 
combination of purified recombinant proteins (EspA, Intimin-531 and Tir)   47 
effectively reduced colonization and shedding of VTEC O157:H7 by cattle 
and that the protection may be enhanced by addtition of H7 flagellin to the 
vaccine preparation. (McNeilly et al., 2009). 
Other studies made on subunit vaccines for Efa1, intimin, and EspA have 
induced high titres of specific IgG and IgA antibodies, but these vaccines 
failed in experimental trials in calves to give any protection against VTEC 
O157:H7 intestinal colonization (Dziva et al., 2007; van Diemen et al., 
2007). 
Research is  currently proceeding into new vaccines that will target 
epitopes of type III secreting proteins from several serotypes of VTEC that 
hopefully will reduce shedding in cattle of more EHEC serotypes than 
VTEC O157:H7 (Potter et al., 2009). 
 
Direct application of therapeutic agents to terminal recta 
A Scottish study has evaluated local treatment with direct application of the 
antisepticum chlorhexidine to the terminal rectum of calves that have been 
experimentally infected with VTEC O157:H7. This treatment was found to 
eliminate “high shedding” and reduce low level shedding in the calves by 
killing VTEC O157:H7 that had colonized the terminal rectum (Naylor et 
al., 2007b). When a group of 11 calves were sampled 3-4 weeks after 
treatment, there was no sign of re-colonizsation.   48
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2  Aims of the thesis 
The main aim of this study was to increase our knowledge of VTEC 
O157:H7 in Swedish cattle and pigs and to establish to what extent VTEC 
O157:H7 isolated from these animals can be held responsible for domestic 
human infections in Sweden.  
 
The specific aims were: 
 
¾ To estimate the prevalence of VTEC O157:H7 in slaughtered cattle in 
Sweden and establish the origin of identified ”positive cattle”. 
¾ To estimate the prevalence of VTEC O157:H7 on Swedish dairy farms 
and to ascertain if there were any differences in farm prevalences 
between different regions in Sweden. 
¾ To examine if there were any associations between VTEC O157:H7 
status and farm size, age of sampled animals and presence of animals other 
than cattle on the dairy farms. 
¾ To estimate the prevalence of VTEC O157:H7 in slaughtered pigs in 
Sweden and establish the origin of identified ”positive pigs”. 
¾ To establish the period during which ”positive pigs” on VTEC 
O157:H7 positive farms were shedding the bacteria and to ascertain if 
any specific factor influenced this period. 
¾ To subtype VTEC O157:H7 strains isolated in prevalence studies on 
cattle and strains isolated from cattle farms linked to human cases, in 
order to establish if any specific VTEC O157:H7 variants were more 
closely associated with human VTEC O157:H7 infections.  
¾ To evaluate the ability of different subtyping methods to distinguish 
between VTEC O157:H7 strains and their potential to identify a 
putative hyper virulent group of VTEC O157:H7 strains that 
predominate in Swedish humans cases.   50
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3  Considerations on Material and 
Methods 
3.1  Methods used in sampling of animals 
Individual faecal samples in the cattle studies were collected directly from 
the rectum, using disposable plastic gloves. The samples were placed in 
plastic pots and sent to the laboratory by the regular postal service without a 
cooling device (except samples collected in the slaughterhouse studies). As 
VTEC O157:H7 can survive for lengthy periods in cattle faeces (46-126 
days) (Fukushima et al., 1999) and slurry (90 days) (McGee et al., 2001) it 
was considered unnecessary to use a cooling device for transportation when 
analyses were initiated only 1-2 days after sampling. 
An alternative sampling method vs. faecal sampling in the cattle studies 
could have been use of rectoanal mucosal swabs (RAMS), i.e. swabbing the 
specific colonization site in terminal rectum (Rice et al., 2003). This method 
has been shown to yield more positive results compared with analysing 
faecal samples (Greenquist et al., 2005). On the other hand analysis of faecal 
samples has proved more efficient than RAMS for detecting VTEC 
O157:H7 in transiently shedding cattle (shedding < 1 week) (Rice et al., 
2003). 
In the farm studies, individual faecal samples were for practical reasons 
sometimes replaced by composite faecal pat samples from pens where faeces 
from up to 10 different pats were included. This method has been shown to 
reduce apparent pen prevalence, compared with collecting individual faecal 
samples (Smith et al., 2004). 
Two other alternative pen-sampling methods are placing “culturing rope 
devices” in the pens that cattle lick, chew or rub against (Smith et al., 2004), 
and sampling faecal bedding material by walking around in the pens with 
absorbent overshoes (Cobbaut et al., 2008).    52
3.2  Method for detection of VTEC O157:H7 
All faecal samples were analysed by qualitative analysis involving 
immunomagnetic separation (IMS), a method that increases sensitivity up to 
seven-fold compared with conventional plating out from an enrichment 
broth (Chapman et al., 1994). 
The samples were diluted 1:10-1:20 in buffered peptone water (BPW) 
and pre-enriched at 37° ± 1°C for 6-8 h. IMS was then performed, where 1 
ml of the enrichment broth was mixed with paramagnetic beads coated with 
antibodies against E. coli O157. Enriched E. coli O157 were allowed to bind 
to the beads, which were then subjected to several washes. After washing, 
the complex of bacteria and beads was spread on selective agar plates which 
were incubated overnight at 37°C. The plates were then screened for 
VTEC O157:H7. 
IMS was performed either directly after 6-8 h incubation or after storing 
the enrichment broth overnight (16-20 h at 6-8°C). When evaluated this 
cold-storage procedure was not found to influence the analysis results 
negatively (Eriksson et al., 1998). 
Pooling of faecal samples together, five and five at analysis, was used to 
reduce costs in the dairy herd study and the slaughterhouse study on pigs. 
However, this procedure has been shown to impair the sensitivity of the 
analyses (Arnold et al., 2008; Sanderson et al., 2005; Eriksson et al., 1998). 
The likelihood that pools would prove VTEC O157:H7 positive increases if 
more than one positive sample is included in the pool and/or if any of the 
included faecal samples contains high a level of VTEC O157:H7. One 
drawback of pooling is that background flora from several faecal samples 
accumulate, thereby interfering with the analysis. To compensate for this, 
faecal samples from animals of the same age and housed together can be 
pooled, as they are more likely to have largely the same gut flora. This 
strategy was utilized in the dairy herd study where the faecal samples were 
pooled according to an age-related sampling list. Also in this study, the 
amount of added faeces from each animal (5 g) exceeded the 1 g added 
faeces in the studies by Sanderson and colleagues and Arnold and colleagues. 
However, pooling probably reduced the apparent prevalence, especially in 
the pig studies where the analyses were performed during the period when 
only 1 g of faeces from individual samples was analysed (see below), while a 
pooled sample consisted of 5 g of faeces (1 g from each sample included).  
IMS is considered as the official standard method for detection and 
isolation of E coli O157:H7 from food samples (Anonymous, 2001) but is 
also generally applied as the standard method in the analyses of animal faecal 
samples. In an evaluation study an IMS-based method was compared with   53 
the performance of a PCR assay by testing series of animal faeces (from 
cattle and sheep) and meat samples artificially contaminated with VTEC 
O157:H7. In this study the IMS-method identified 20/21 (95%) of the 
faeces samples at the inoculation level 10
1 cfu/10 g faeces and 2/21 (10%) at 
inoculation levels 10
0 cfu/g faeces (Islam et al., 2006).  
The outcome of the VTEC O157:H7 IMS analyses of cattle faecal 
samples is very much dependent on background flora in the analysed faeces, 
amount of faeces included in the analysis, the individual laboratory´s 
performance and the enrichment procedure used. This is evident in the 
results from the Swedish cattle slaughterhouse studies, presented in Table 9, 
page 36. In the first study, 1996-97, 10 g of faeces were pre-enriched in 90 
ml BPW giving an apparent prevalence of 1.2%. In 1997-98, when the 
analyses were conducted by another laboratory (not the National Veterinary 
Institute, NVI) the amount of faeces analysed was reduced to 1 g and the 
sample was enriched in 20 ml BPW (same enrichment protocol as used e.g. 
in Scotland). The apparent prevalence then fell to 0.3%. In 1999 the amount 
of faeces was again 10 g enriched in 90 ml BPW, which increased the 
apparent prevalence to 0.7%. Finally, when the analyses in 2000 were 
transferred back to NVI (10 g of faeces enriched in 90 ml BPW), the 
apparent prevalence increased further, to 1.7%. Moreover, in the 
slaughterhouse prevalence study performed in 2005-06, a new improved 
enrichment protocol was introduced, where 10 g of faeces was enriched in 
90 ml modified Tryptic Soy Broth (mTSB) (with of 20 mg/l of novobiocin 
added), the enrichment period was prolonged to 18-24 h and the 
temperature was raised to 41.5°±0.5°C. With this new enrichment protocol 
the apparent prevalence increased to 3.4%. In the most recent 
slaughterhouse study, in 2008-09, the mTSB enrichment protocol was again 
used and the prevalence in faeces samples was almost identical (3.3%) with 
the results from 2005-06. 
3.3  Detection of Verotoxins 
VT secreted from VTEC can be detected by Vero cell cytotoxicity assay, 
enzyme immunoassay, latex agglutination assay and colony immunoblot, 
several tests of these being commercially available (reviewed by Karch et al., 
2005). With these methods the actual verotoxins are detected. With Vtx-
ELISAs, one can also quantify and compare levels of VT production 
between different strains (Dowd & Williams, 2008; Ziebell et al., 2008) 
which might have been interesting, e.g., for comparing VT2 production 
between VTEC O157:H7 strains in Paper V.   54
In the present studies it was not investigated if the bacteria produced VT; 
instead the genes encoding VTs by different PCR assays were identified. 
However, a positive PCR reaction does not confirm that the bacteria can 
produce VT, as the PCR reaction detects only a part of the VT gene. There 
may have been events such as mutations, insertions and deletions that 
rendered the gene unfunctional or unexpressed. 
3.4  Phage typing 
Phage typing, by published methods, was performed at the Laboratory of 
Enteric Pathogens (Central Public Health Laboratory, London, England) 
(Khakhria et al., 1990; Ahmed et al., 1987). 
After the slaughterhouse survey in 1996-97 all the 37 VTEC O157:H7 
isolates collected were sent for phage typing, six of them were typed as 
having a RDNC pattern (reacted but did not conform). When the next set 
of strains was submitted, in 2003, these six strains were sent again. This time 
three of those that at the previous typing proved RDNC were of phage 
type 8, a type that was also included in the typing scheme on the first typing 
occasion. These results illustrate that the correct phage type can sometimes 
be difficult to determine and that phage typing appears not to be completely 
reproducible. This also explains why the phage typing results of the survey 
performed in 1996-97 differ between Paper I and Paper IV. 
3.5  Choice of molecular typing methods 
For subtyping the VT2 genes, two different methods have been used, 
conventional PCR-RFLP (Pierard et al., 1998) (Paper IV) and a method 
based on partial sequencing of the VT2 gene (Persson et al., 2007) (Paper 
V). In the latter method the nucleotide sequence is defined from partial 
sequencing of the most variable part of the vtxAB2 operon (Persson et al., 
2007). This method enabled division of the VT2 variants; vtx2 and vtx2c, into 
further variants where the new ones were defined by the 159 amino acids 
encoded by the sequenced DNA fragment. When several vtx2 variants were 
present this could be detected as double peaks in each position where the 
two VT2 variants differed in nucleotide composition.  
Pulsed-Field Gel Electrophoresis (PFGE) has been the basis for subtyping 
of all VTEC O157:H7 strains in these studies. By cutting the whole 
bacterial genome with specific macro-restriction enzymes, like XbaI, a 
varying number of DNA fragments of differing size are obtained. These 
fragments can be separated by PFGE according to a specific protocol.   55 
Afterwards the fragments can be visualized as band patterns on agarose gels. 
In Paper V another typing method was evaluated; multi-locus variable 
number tandem repeat analysis (MLVA). MLVA does not analyse the whole 
genome, instead it focuses on specific loci and quantifies number of so-
called tandem repeats in these loci. The resulting information is a number 
series of tandem repeats in the 8 different loci studied, which can be 
compared between different strains. Comparison of different band patterns 
by PFGE is more dependent on correct interpretation of gel images and is 
therefore more difficult to standardize. As PFGE and MLVA are based on 
different principles it was interesting to compare how they distinguish 
between the selected strains (Paper V).  
A subtyping method based on single nucleotide polymorphism (SNP) 
was used in Paper V to detect single mutations localized in specific positions 
of four specific SNPs (Riordan et al., 2008). By establishing which 
nucleotides were present in different SNPs, it was possible to establish if 
VTEC O157:H7 strains belonged to any of the evolutionary clades 1, 2, 3 
or 8 described by Manning and colleagues (Manning et al., 2008). To verify 
that clade 8 strains were correctly identified another SNP method was 
included. This one determined the nucleotide variants in four SNP in the 
rhsA gene by partial sequencing and the results could be used to specifically 
verify the clade 8 strains (Liu et al., 2009). 
3.6  Statistics 
The statistics used in the studies are standard methods. In Paper II, however, 
the variable herd size was analysed in a novel way. It was assumed that the 
risk of a dairy herd being VTEC O157:H7 positive, depending on the 
variable herd size, was not linear. Rather, the incremental increase in risk 
would be higher from 20 to 100 cows than from 200-280 cows. Based on 
comparative considerations and using the approach in bacteriology for 
modeling infectious doses, the following formula was applied for the 
variable herd size:  
 
1-exp[-(number of cows * prevalence)]  
 
where the prevalence among the animals was set to be 1.034% (based on the 
calculated individual prevalence from the observed prevalence in the pooled 
samples). When this formula was applied to the variable “herd size” the total 
risk was presented as a function that fitted the assumed hypothesis of 
increase in risk as a function of number of cows (see Fig. 10).    56
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Figure 10. Relationship between the number of dairy cows and probability of a herd being 
deemed VTEC O157 positive if the variable herd size is presented as 1-exp [- (no.cows * 
prevalence)]. The total risk asymptotically approaches 1 for a infinite number of cows.   57 
4  Results and Discussion 
4.1  The prevalence studies on cattle 
The first slaughterhouse study on cattle was launched as a survey 1996-97 
and the sample size in this study was set to detect a very low prevalence of 
VTEC O157:H7 (prevalence of 0.1% with a 90% confidence level). The 
prevalence turned out to be 1.2% (CI95 0.8-1.6) which was ten-fold higher 
that expected. This prevalence was in the lower range but nevertheless 
comparable to results from slaughterhouse studies in other countries in 
Europe (see Table 10, page 36). However, it is very difficult to compare 
results between different prevalence studies, as study design, number of 
samples, sampling strategy, amounts of faeces analysed, enrichment protocols 
etc, all vary in different studies. The effects of such factors are very explicitly 
demonstrated in the Swedish slaughterhouse studies, where relatively small 
changes in methodology led to considerable changes in apparent prevalence 
in different years (see above under “Method for detection of VTEC 
O157:H7”).  
The results from the survey and the subsequent slaughterhouse studies 
have confirmed the same relationships in Sweden as reported from other 
countries, i.e. that the prevalence is higher during the warmer season of the 
year (Barkocy-Gallagher et al., 2003; Paiba et al., 2003) and that the bacteria 
are more frequently found in younger than in older animals (Paiba et al., 
2003; Nielsen et al., 2002; Heuvelink et al., 1998b). Moreover, the results 
have demonstrated the importance of slaughter hygiene at Swedish 
slaughterhouses, especially after VTEC O157:H7 in the later studies was 
found in such a high prevalence in ear samples (Boqvist et al., 2009) (see also 
Table 9, page 36).  
With the exception of a few positive findings in 1999-2000, all VTEC 
O157:H7 positive animals have been geographically localized to the postal 
code of the farm of origin. Furthermore, the geographical postal codes of all   58
positive farms in the dairy herd study are known. The geographical 
distribution of the registered postal codes from the cattle prevalence studies 
performed during 1996-2002 is mapped in Paper IV. Generally, VTEC 
O157:H7 were detected in the areas in Sweden where cattle density is 
known to be high, see Fig. 9, page 34. No positive samples were detected in 
sampled animals from northern Sweden. These maps are consistent with the 
map in Paper II, where the prevalence of VTEC O157:H7 in dairy herds is 
shown. 
The varying prevalences observed in the slaughterhouse prevalence 
studies among cattle originating from different geographical regions are 
consistent with observations in other countries. In a Finnish slaughterhouse 
study, no VTEC O157:H7 positive animals were found in northern Finland 
(Lahti et al., 2001) and more positive samples were also found from 
slaughterhouses in eastern Great Britain compared to slaughterhouses from 
the north of Great Britain (Paiba et al., 2002). 
In the dairy herd study the livestock association (LA) “Halland Husdjur” 
situated on the Swedish southwest coast presented the highest prevalence 
(23.3%) of all LAs and LA “Halland Husdjur” was also included in the final 
fitted multivariate model as an increased risk for a herd being VTEC 
O157:H7 positive.  
In Paper IV all the cattle farms that were associated with human cases 
during 1996-2002 are mapped. Most of these farms (61%) were located in 
Halland and at all those farms the causative agent was the variant VTEC 
O157:H7 (PT4;vtx2,vtx2c) (see below). Most of the farms associated with 
human cases during this period were located in southwest Sweden, with 
only one farm in the east-central Sweden and one farm in Skåne province in 
the south. In latter years, more farms linked to human cases of VTEC 
O157:H7 have been found in Skåne and in other parts of Sweden, which 
correlates well with the observation in Paper IV that VTEC O157:H7 
(PT4;vtx2,vtx2c) strains appeared to be spreading within Sweden 
Repeated sampling, i.e. longitudinal studies, produces higher and more 
accurate prevalence estimates than studies based on one occasion  only 
(Synge et al., 2003; Hancock et al., 1997). The dairy herd study was based 
on only one sampling occasion and the observed prevalence of VTEC 
O157:H7 would probably have exceeded 8.9% if repeated sampling in the 
herds had been performed. Also, pooling of samples may have lowered 
prevalence, whereas the new enrichment protocol, introduced in 2005 with 
mTSB, might have increased diagnostic sensitivity and led to higher 
observed prevalence. However, the observed prevalence of 8.9% is within   59 
the range of what has been reported from other studies from Europe (see 
Table 8, page 35).  
An increase in herd size from 20 to 100 cows was identified as a risk factor 
in the dairy herd study and this variable was included in the final fitted 
multivariate model with an OR of 3.5. In a study on Canadian feedlots a 
significant correlation was found between prevalence rate and the number 
of pens occupied by cattle within the feedlots; in addition there was a 
correlation with cattle density in the pens (Vidovic & Korber, 2006). Other 
studies on dairy and beef cattle farms have not reported any correlation 
between herd size and VTEC O157 prevalence (Cobbaut et al., 2009; 
Nielsen et al., 2002; Wilson et al., 1998; Garber et al., 1995). The reason for 
this might be that the other studies have included few farms with herd size 
< 50 cows. Another explanation could be that the assumption in Paper II is 
correct, i.e. that the increased risk associated with number of cows is not 
linear and that this study was able to detect the increased risk due to the 
specific adjustments in the statistics with the herd size variable. Furthermore, 
the formula used in the statistics was probably not the optimal function for 
describing this relationship. Based on the knowledge we have today, 
probably the best formula would have been a function based on the 
prevalence of high-shedders in the herd, where one or more high-shedders 
in a herd would indicate a considerable likelihood of a circulating, and 
therefore persistent, VTEC O157 infection. 
The observation that the risk of a farm being VTEC O157:H7 positive 
increased if median age was lowered from 10 months to 3 months (OR= 
2.1 in multivariate model) is consistent with what other studies have 
reported, that prevalence is higher in younger animals (Paiba et al., 2003; 
Nielsen et al., 2002; Heuvelink et al., 1998b). 
Several studies have, like in Paper III (OR=1.9), reported significant 
results indicating that presence of pigs on dairy farms is a risk factor for a 
cattle herd being positive for VTEC O157:H7 (Gunn et al., 2007) 
(OR=2.4) (Schouten et al., 2004) (OR= 3.4), (Cernicchiaro et al., 2009) 
(OR=15.5). Conversely, one study claims that the risk was reduced if pigs 
were present on a farm with beef suckler cows (Synge et al., 2003) 
(OR=0.2). No explanation as to why in several studies pigs are associated 
with an increased risk that cattle farms would be VTEC O157:H7 positive 
has been presented. There are theories that some unidentified management 
routines in mixed herds with both cattle and pigs, can increase the risk of 
VTEC O157 infection in cattle. Manure management, housing practices 
and supposedly greater movement of animals in mixed herds than in non-  60
mixed herds, are all factors mentioned in these discussions (Cernicchiaro et 
al., 2009).  
4.2  Pig studies 
The apparent prevalence found in Swedish slaughter pigs (Paper III) was 
very low (0.08%) and the two identified VTEC O157:H7-positive pigs 
were traced back to their farms of origin; both of them kept ruminants and 
pigs. The prevalence is comparable to what has been observed in Norway 
(Johnsen et al., 2001) and Great Britain (Milnes et al., 2008) (see Table 12, 
page 41).. 
Repeated sampling on the four VTEC O157:H7 positive farms that kept 
both ruminants and pigs showed that the strains isolated from pigs and 
ruminants presented identical or very similar PFGE pulsotypes. The 
bacterium could be detected in pig samples on sequential sampling occasions 
and there was evidence that direct or indirect contact with ruminants was of 
importance in maintaining VTEC O157:H7 infection in pigs. On one of 
the farms VTEC O157:H7 prevailed, and could be detected in pig faecal 
samples for 11 months. It was also demonstrated that if VTEC O157:H7 
positive young pigs were allocated to an environment free from ruminants, 
they gradually ceased shedding VTEC O157 and the bacterium could not 
be detected in any of the faecal samples collected 9 weeks after the pigs had 
been moved from the herd of origin. The conclusion from Paper III was 
that the prevalence in the Swedish pig population was very low and that 
pigs seemed unlikely to contract a VTEC O157:H7 infection unless they 
had direct or indirect contact with ruminants. 
One explanation for the low prevalence seen in pigs could be that 
intimin (eaeA) and the TTSS which is essential for colonization in cattle do 
not improve colonization of VTEC O157:H7 in pigs (Jordan et al., 2005). 
However, pigs ought to be considered as a potential reservoir for VTEC 
O157:H7. Experimental studies have shown that pigs do not have any 
innate resistance to infection; they can shed the bacterium for periods up to 
4 months and can also transmit infection to other pigs in a herd (Cornick & 
Vukhac, 2008; Cornick & Helgerson, 2004; Booher et al., 2002).  
Some studies have detected higher prevalences in pigs than in cattle. In a 
Chilean study the prevalence of VTEC O157 in 120 slaughtered pigs was 
10.8% whereas 136 sampled steers rendered a prevalence of only 2.9% 
(Borie et al., 1997). In another study from Mexico 60 faecal samples were 
collected from each of four cattle farms and four pig farms; and the 
prevalences were 2.1% in pigs and 1.25% in cattle (Callaway et al., 2004b). 
Moreover, in an investigation of public amenity premises in England and   61 
Wales, a significant association was found between presence of VTEC O157 
and the number of species sampled, size of enterprise, presence of young 
cattle and presence of adult pigs (Pritchard et al., 2000), implying that the 
presence of adult pigs contributes to greater risk of VTEC O157:H7 
infections for humans on these premises. 
The results in paper III do not indicate that pigs, at least not in Sweden, 
are an important source of infection for humans, though the relationship 
between pigs and cattle is puzzling. It seems that keeping both pigs and 
cattle on mixed farms increases the risk of pigs shedding the bacterium to a 
detectable degree. On the other hand, our results (as well as results in other 
studies, see above), indicate that keeping pigs together with cattle on mixed 
farms increases the risk of cattle shedding VTEC O157:H7. More studies are 
needed to explain this apparently contradictory relationship. 
 
4.3  Characterization of VTEC O157:H7 isolates 
The strains collected in the different cattle prevalence studies during 1996-
2002 were all isolated by random sampling and were therefore considered to 
reflect the VTEC O157:H7 strains prevalent in the Swedish cattle 
population during that period. The subtyping results from the first 
slaughterhouse survey (Paper I), had already presented a varied picture 
regarding verotoxin composition, PFGE pulsotypes and phage types in the 
37 strains obtained. When comparing strains from the prevalence studies 
isolated during 1996-2002 (Paper IV), the conclusion was that there was a 
wide variation in strains present in the cattle population. Ten different phage 
types were identified as well as several not previously described types 
(RDNC types) and all these could be further divided into different PFGE 
pulsotypes. However, three different phage types predominated, PT4 (28%), 
PT8 (33%) and PT14 (18%).  
The fact that a diverse picture was evident even in the first slaughter-
house survey leads to speculation as to how long VTEC O157:H7 have 
prevailed in the Swedish cattle population. It seems unlikely that such a 
diverse composition of strains could have been introduced over a short 
period of time. Therefore, strains of VTEC O157:H7 probably prevailed in 
the Swedish cattle population long before 1995-96, i.e. before the increase 
in human incidence was observed. This would imply that the VTEC 
O157:H7 strains present before 1995 were less virulent or not so effectively 
transmitted to humans as new strains putatively introcuded after 1995-96, 
though it could mean that VTEC O157:H7 infections in humans were   62
under-diagnosed in Sweden before 1995-96, when new diagnostic tools 
were introduced. 
Among the 18 farms associated with human cases during 1996-2002 a 
specific variant of VTEC O157:H7 was predominant as it was found on 16 
(89%) of the 18 farms. These strains were of phage type 4, carried two VT2 
genes (vtx2 and vtx2c) and presented similar pulsotypes when typed by pulsed 
field gel electrophoresis (PFGE). During the same period, strains of this 
variant were also isolated in the slaughterhouse studies (~27% of isolated 
strains) and dairy herd study (21% of positive farms). Moreover, VTEC 
O157:H7 (PT4;vtx2;vtx2c) strains (called SMI H variants by SMI) also 
accounted for more than two-thirds of the VTEC O157:H7 isolates from 
Swedish domestic cases during 2001-2007 (personal communication, Sven 
Löfdahl, SMI). 
As it was suspected that VTEC O157:H7 (PT4;vtx2;vtx2c) strains, or other 
strains isolated from farms linked to human cases, were more virulent, a 
subset of strains (n=45) was analysed by a microarray assay and PCRs 
targeting selected virulence genes. Generally speaking the results of that 
study supported our previous conclusions. The observed variability among 
strains isolated in prevalence studies in terms of pulsotype, phage type and 
VT2 type was to some extent reflected by the variable absence (or presence) 
of virulence genes, while strains belonging to VTEC O157 (PT4;vtx2;vtx2c) 
presented virtually identical virulence gene patterns with a complete set-up 
of LEE genes and other major virulence genes. However, no specific 
virulence markers distinguishing these strains from the other strains could be 
observed (Söderlund et al., In manuscript) 
In Paper V the same subset of strains (n=45) as used by Söderlund and 
colleagues was subjected for further subtyping, using PFGE, MLVA and two 
SNP typing methods. In addition the vtx2 and vtx2c genes were subtyped by 
partial sequencing. It was found that all VTEC O157:H7 (PT4;vtx2;vtx2c) 
strains belonged to a specific hyper-virulent clade of strains, clade 8, that is 
associated with more severe illness in humans (Manning et al., 2008). The 
utilized SNP typing method (Riordan et al., 2008) proved to be a reliable 
and convenient tool for rapid identification of clade 8 strains and this 
method can be very useful in the future for rapid identification of strains 
belonging to the variant VTEC O157:H7 (PT4;vtx2;vtx2c). 
In the partial sequencing of the vtx2 genes it was not possible to identify 
any unique vtx2variants among the VTEC O157:H7 (PT4;vtx2;vtx2c) strains 
or other strains linked to human cases. The MLVA subtyping results 
correlated closely with the PFGE results regarding clustering of strains, 
though for a small subset of strains the two methods distinguished differently   63 
between the strains. Moreover, MLVA was able to divide some strains with 
indistinguishable PFGE (XbaI) pulostypes into distinct MLVA variants, 
which also tallied closely with the epidemiological history of the strains. 
However, the converse was also observed, e.g. that PFGE was able to divide 
strains with the same MLVA variant into distinct PFGE patterns that 
correlated well with epidemiological history. It was also found, consistent 
with results obtained by Hyytiä-Trees and colleagues, that when combined 
XbaI-BlnI PFGE data was used, this led to better concordance between the 
MLVA and the PFGE results (Hyytia-Trees et al., 2006). The two methods 
can be considered as complementary and the best information is obtained if 
they are run in parallel.  
In the prevalence studies on slaughtered cattle, during 1996-2002, four 
VTEC O157:H7 strains of PT4 were isolated that carried only the vtx2 gene 
(no vtx2c gene). Subsequently, in 2007, a VTEC O157:H7 (PT4;vtx2) strain 
was isolated from one farm associated with a human case. These strains 
presented PFGE pulsotypes similar to those of VTEC O157:H7 
(PT4;vtx2;vtx2c) and it was therefore suspected that they were of clade 8. 
When the strain associated with the human case and two isolates from the 
prevalence studies were SNP typed, with the method according to Riordan 
and colleagues, it could be confirmed that they all belonged to clade 8. 
These results are consistent with the decription of clade 8 strains carrying 
either a single vtx2 gene, or vtx2 and vtx2c in combination (Manning et al., 
2008). 
The fact that variant VTEC O157:H7 (PT4;vtx2;vtx2c) belongs to the 
hyper-virulent clade of VTEC O157:H7 strains, is consistent with its pre-
dominance among human cases and farms linked to human cases since 1996. 
The two large Swedish food-borne outbreaks caused by VTEC O157:H7 
(PT4;vtx2;vtx2c) strains have both resulted in high frequencies of HUS, the 
sausage outbreak (30% HUS), (Sartz et al., 2007) and the lettuce outbreak 
(8% HUS) (Söderström et al., 2008), which also is typical of clade 8 strains 
(Kulasekara et al., 2009; Manning et al., 2008). 
It has been described that clade 8 strains can produce significantly larger 
amounts of VT2 than lineage II strains (VTEC O157:H7 strains that are 
more frequently isolated from cattle than humans and thereby considered as 
less virulent for humans) (Zhang et al., 2009). However, other strains than 
clade 8 also have the same, or even greater capacity, to produce VT2 
(Zhang et al., 2009; Manning et al., 2008). Thus, the high virulence seen in 
clade 8 strains must also be caused by some other factor/factors not yet 
identified.    64
In a recent study a clade 8 strain isolated from a food-borne outbreak in 
the USA, “the spinach outbreak”, was sequenced. The authors identified 
seven putative virulence determinants in the genome of this bacterium and 
suggested that an intact gene for anaerobic nitric oxide reductase, norV, 
could be correlated to the greater virulence of these strains (Zhang et al., 
2009).  
The most frequent PFGE pattern found from human VTEC O157:H7 
isolates in Sweden has been designated by SMI “SMI-H”. This PFGE 
pattern has been prevalent in Sweden since it first was observed in 1996 in 
isolates from Halland. By comparing the PFGE pattern of “SMI-H” with 
PFGE patterns in American publications, Dr. Sven Löfdahl at SMI was able 
to detect a similarity in the banding pattern between American strains and 
“SMI-H”. When a TIF file with this PFGE pattern was sent to the Center 
of Disease Control and Prevention (CDC) Atlanta, USA, they could 
confirm that the PFGE “SMI-H” was identical to the most frequently 
observed PFGE pattern among isolates from American patients, 
“EXHX01.0047”. Furthermore, this PFGE banding pattern 
“EXHX01.0047” has previously been shown to be identical to the most 
common PFGE pattern observed in isolates from Argentinian patients 
“AREXHA26-011 (personal communication Peter Gerner-Smith, CDC, 
Atlanta, USA; Löfdahl, 2008). These are only preliminary data and the 
observations require further verification, but it is intriguing that VTEC 
O157:H7 (PT4;vtx2;vtx2c) strains with the same pulsotypes are commonly 
isolated from human cases in all these three countries. 
4.4  VTEC O157:H7 colonisation in cattle 
Interestingly, in humans, VTs from VTEC O157:H7 elicit an enhanced 
immune response and thereby make the endothelial cells more vulnerable to 
the damaging effects of VTs (reviewed by Palermo et al., 2009; and Proulx 
et al., 2001). By contrast in cattle, it has been suggested that VTs modulate 
the bovine immune response in the intestines in order to improve 
colonization (Menge et al., 2003; Hoey et al., 2002; Magnuson et al., 2000). 
In Scotland the dominant strains of VTEC O157:H7 are of phage type 
21/28. These strains are responsible for 72% of human cases in Scotland and 
are associated with more severe disease (e.g. HUS) than other VTEC 
O157:H7 strains in Scotland. VTEC O157:H7 of PT21/28 are isolated 
from ~50% of Scottish cattle sampled (reviewed by Chase-Topping et al., 
2008). The odds for cattle shedding phage type 21/28 are found to be more 
than twice as high in high-shedding cattle as in low-shedders. This could   65 
mean that these VTEC O157:H7 strains are more effective in colonizing the 
terminal rectum than other VTEC O157:H7 strains (Chase-Topping et al., 
2007). It can be hypothesized that VTEC O157:H7 (PT4;vtx2;vtx2c) strains 
likewise could be isolated more frequently from high-shedding cattle in 
Sweden. However, further studies are needed to investigate such a 
relationship. 
4.5  Halland county 
At the regional hospital in Halland, VTEC O157:H7 was very rarely 
isolated from human stool samples before 1995. From November 1994 to 
November 1995 a screening study for EHEC was undertaken. All stool 
samples from patients with bloody diarrhea under the age of 15 were 
screened for VTEC O157:H7 by a newly introduced culturing method. 
During the first 9 months of the study, all samples (approx. 10,000) proved 
negative for VTEC O157:H7. In autumn 1995 the first four strains of 
VTEC O157:H7 were isolated from children with diarrhea and in June, 
two additional strains were isolated. All strains were defined by DNA 
subtyping as belonging to variant VTEC O157:H7 (PT4;vtx2,vtx2c) (personal 
communication Torvald Ripa M.D, Assistant Professor at the Department 
of Clinical Microbiology & Infection Control, Halmstad Hospital, Halland, 
Sweden). The fact that no VTEC O157:H7 strains were detected during the 
first 9 months of the study leads to speculation that VTEC O157:H7 
(PT4;vtx2,vtx2c) could have been  introduced as a new human pathogen into 
Halland in 1995. 
Since 1996 Halland county has had the highest domestic incidence of 
VTEC in all Sweden varying during 1997-2008 between 2.1 and 
16.6/100,000 (mean incidence 7.0/100,000 inhabitants) (see Fig. 8, page 
32). During 1996-2002, 11 (61%) of the 18 cattle farms that were linked to 
human VTEC O157 cases were located in Halland and all isolated strains 
from these farms belonged to the variant VTEC O157:H7 (PT4;vtx2,vtx2c).  
In the first slaughterhouse prevalence study of 1996-1997, strains of 
VTEC O157:H7 (PT4;vtx2,vtx2c) were isolated only in cattle from Halland 
and constituted, in this study, approx two-thirds of the VTEC O157:H7 
isolates from Halland. In the subsequent prevalence studies and dairy herd 
study this variant has been isolated in other regions of Sweden. Moreover, 
this spread coincided with the observation that strains of VTEC O157:H7 
(PT4;vtx2,vtx2c) were more frequently isolated from farms linked to human 
cases in other parts of Sweden, than Halland. One might therefore have 
reason to speculate that VTEC O157:H7 (PT4;vtx2,vtx2c) was introduced   66
into the cattle population of Halland around 1995 and has since spread to 
cattle population in other parts of Sweden. 
Interestingly, a similar hot spot of high VTEC O157:H7 prevalence in 
cattle and high incidence in human cases is found in Grampian region, in 
northeast Scotland. Grampian has an infection rate of 9.2 human 
cases/100,000 per inhabitants and an apparent prevalence of 9.2% in cattle 
and 6.5% in sheep. In Grampian however the predominant strain is a VTEC 
O157:H7 of phage type 21/28 (Strachan et al., 2005). 
4.6  Future perspectives 
To be able to reduce the human incidence of VTEC O157:H7 infections in 
Sweden, an approach that aims to reduce its prevalence in the cattle 
population is needed. This is important as exposure from the environment is 
a common infection route in sporadic human cases (Strachan et al., 2006). In 
addition, other measures are needed, such as continuous information-
campaigns describing how people can reduce the risk of infection when 
visiting farms, by practising hygiene routines etc. Also, efforts to ensure that 
the bacterium does not enter the food chain are of great importance. 
 
However, if efficient measures should be introduce in cattle farms there are 
still some knowledge gaps that need to be filled, such as: 
 
¾ What are the most important routes of infection/introduction of VTEC 
O157:H7 in Swedish cattle herds (other than introduction of VTEC 
O157:H7 positive animals).  
¾ What measures would be most effective and feasible for reducing 
prevalence, even possibly to eradicate, the bacterium in VTEC O157:H7 
positive cattle herds. 
¾ Is it possible to reduce the prevalence, or eliminate the presence, of so-
called “high-shedders” in cattle herds, as these animals account for the 
greater part of VTEC O157:H7 shed and may be responsible for 
maintaining the infection in cattle herds.  
¾ Should measures in cattle herds be concentrated on certain VTEC 
variants that appear to be more virulent for humans, such as VTEC 
O157:H7 (PT4;vtx2,vtx2c) and if so, how should such bacteria be defined 
and detected.    67 
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